{"gene":"ITK","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":1992,"finding":"ITK encodes a 72-kDa protein-tyrosine kinase specifically expressed in the T-cell lineage; its mRNA is induced by IL-2 in parallel with IL-2Rα, identifying it as an IL-2-inducible T-cell kinase.","method":"Molecular cloning, Northern blot analysis of mouse tissues and cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — original cloning and expression characterization, T-cell-specific expression replicated across many subsequent studies","pmids":["1280821"],"is_preprint":false},{"year":1994,"finding":"ITK is physically associated with CD28 in Jurkat T cells and undergoes rapid tyrosine phosphorylation and activation within 30 seconds of CD28 ligation, preceding phosphorylation of VAV, placing ITK among the earliest events in CD28 signaling.","method":"Co-immunoprecipitation, in vitro kinase assay, Western blot with phosphotyrosine antibodies","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP and kinase activity assay in Jurkat cells, single lab but consistent with subsequent studies","pmids":["7524075"],"is_preprint":false},{"year":1995,"finding":"Itk-deficient mice have decreased numbers of mature thymocytes and reduced T-cell proliferative responses to allogeneic MHC stimulation and anti-TCR cross-linking, but respond normally to PMA plus ionomycin or IL-2, establishing Itk as required for proximal TCR signaling events in T-cell development.","method":"Gene targeting (knockout mice), flow cytometry, proliferation assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with multiple defined phenotypic readouts, replicated across multiple subsequent studies","pmids":["8777721"],"is_preprint":false},{"year":1995,"finding":"ITK binding to CD28 is dependent on the presence of p56Lck; Lck and Fyn phosphorylate CD28 at Tyr-191 of the YMNM motif, inducing increased PI3K and GRB-2 SH2 binding to CD28, whereas ZAP-70 and ITK failed to phosphorylate CD28 at this site, placing ITK downstream of Lck in CD28 costimulatory signaling.","method":"Co-expression studies, in vitro kinase assays, SH2 domain binding assays, phosphatase digestion","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal in vitro methods, single lab, key negative result (ITK does not phosphorylate CD28 YMNM) mechanistically informative","pmids":["7568038"],"is_preprint":false},{"year":1995,"finding":"Upon FcεRI cross-linking on mast cells, Itk is activated and its pleckstrin homology domain directly interacts with multiple PKC isoforms in vitro; PKC phosphorylates the PH domain of Itk and PKC isoforms co-immunoprecipitate with Itk in intact mast cells, with PKC inhibition attenuating Itk tyrosine phosphorylation and activity.","method":"Co-immunoprecipitation, in vitro kinase assay, GST pulldown, PKC inhibitor treatment","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct in vitro binding and kinase assays plus cell-based co-IP, single lab","pmids":["7561053"],"is_preprint":false},{"year":1996,"finding":"The Itk SH3 domain binds to proline-rich sequences in T-cell lysates; under stringent conditions it binds Sam68, Wiskott-Aldrich Syndrome protein (WASP), and hnRNP-K, overlapping but distinct from Src-family SH3 binding sites on these proteins.","method":"Phage display library screening, SH3 domain pulldown/binding assays with T-cell lysates and deletion mutants","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vitro SH3 binding assays with multiple substrates, optimal motif defined, single lab","pmids":["8810341"],"is_preprint":false},{"year":1996,"finding":"CD2 ligation induces tyrosine phosphorylation and activation of ITK in Jurkat T cells and peripheral blood T cells; this CD2-mediated activation of ITK requires LCK expression but not surface expression of the CD3 zeta chain.","method":"Co-immunoprecipitation, in vitro kinase assay, Jurkat cell mutant panel","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — kinase activity assay and co-IP with defined mutant cell lines establishing LCK requirement, single lab","pmids":["8943565"],"is_preprint":false},{"year":1997,"finding":"Lck directly phosphorylates Itk at Tyr-511 in the activation loop of the kinase domain using recombinant baculovirus-expressed proteins; phosphorylation at Tyr-511 is required for Itk kinase activity, as the Y511F mutant is catalytically inactive.","method":"Baculovirus co-expression, in vitro kinase assay with recombinant proteins, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with recombinant proteins plus mutagenesis, replicated in subsequent studies","pmids":["9312162"],"is_preprint":false},{"year":1997,"finding":"Src-induced activation of ITK requires PI3-kinase activity and the pleckstrin homology domain of ITK; the PH domain binds D3-phosphorylated inositol phosphates, and membrane targeting of ITK without the PH domain rescues Src-induced activation, demonstrating that PH-domain-mediated membrane recruitment is the critical step.","method":"Coexpression in COS cells, PI3K inhibitor treatment, PH domain deletion and membrane-targeting mutants, membrane fractionation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in cells with multiple domain mutants, lipid binding shown, PI3K dependence pharmacologically confirmed, single lab","pmids":["9326591"],"is_preprint":false},{"year":1997,"finding":"The Itk SH3 domain forms an inducible complex with CD28 mediated by the N-terminal diproline motif of CD28; site-directed mutagenesis of the N-terminal diproline abolishes the association, and N-terminal diproline peptides activate Itk kinase activity to levels similar to CD28 cross-linking.","method":"Co-immunoprecipitation, site-directed mutagenesis of CD28 diproline motifs, peptide competition, in vitro kinase assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis defining binding site combined with co-IP and kinase activity assay, mechanistic detail confirmed","pmids":["9317120"],"is_preprint":false},{"year":1997,"finding":"Itk negatively regulates CD28-mediated T-cell proliferation: Itk-deficient T cells show severely compromised CD3-mediated proliferation but significantly elevated CD28 co-stimulatory proliferative responses, indicating Itk has distinct roles in CD3 versus CD28 signaling pathways.","method":"Knockout mouse T-cell proliferation assays with anti-CD3 and anti-CD28 stimulation","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype, single lab, unexpected negative regulatory role","pmids":["9221751"],"is_preprint":false},{"year":1997,"finding":"Itk is required for CD2-mediated IL-2 promoter activation and NFAT activation in Jurkat T cells; kinase-inactive Itk mutant expression reduces IL-2 promoter activity and NFAT activation downstream of CD2, TCR/CD3, and CD28 stimulation.","method":"Transient transfection of kinase-dead Itk mutant, IL-2 promoter-luciferase reporter assay, NFAT activation assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase-dead dominant-negative approach with reporter readouts, single lab","pmids":["9130632"],"is_preprint":false},{"year":1998,"finding":"Itk-deficient T cells release normal calcium from intracellular stores upon TCR stimulation but fail to open plasma membrane calcium channels; TCR-induced IP3 generation and PLC-γ1 tyrosine phosphorylation are substantially reduced, while TCR-ζ and ZAP-70 are phosphorylated normally, establishing that Itk functions downstream of or in parallel to ZAP-70 to facilitate IP3 production and capacitative calcium entry.","method":"Calcium flux measurement (fura-2), thapsigargin treatment, IP3 measurement, phosphotyrosine Western blot in Itk-/- T cells","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical assays in genetic KO, replicated and extended by many subsequent studies","pmids":["9584150"],"is_preprint":false},{"year":1999,"finding":"Combined deletion of Tec kinases Rlk and Itk causes marked defects in TCR-induced proliferation, cytokine production, apoptosis, and adaptive immune responses; molecular events immediately downstream of TCR are intact, but intermediate events including IP3 production, calcium mobilization, and MAP kinase activation are impaired, establishing Tec kinases as critical regulators of PLC-γ activation.","method":"Double-knockout mice, in vitro T-cell assays (proliferation, cytokine), IP3 measurement, calcium flux, ERK activation, in vivo Toxoplasma gondii infection model","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple orthogonal readouts in double-KO, in vitro and in vivo, widely replicated","pmids":["10213685"],"is_preprint":false},{"year":1999,"finding":"A novel adaptor protein RIBP, identified by yeast two-hybrid screening, physically interacts with both Itk and Rlk/Txk; RIBP-knockout mice show impaired TCR-induced T-cell proliferation and defective IL-2 and IFN-γ but not IL-4 production, linking RIBP-Itk interaction to TCR signal transduction.","method":"Yeast two-hybrid screen, co-immunoprecipitation, knockout mouse with T-cell functional assays","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus genetic KO, single lab","pmids":["10587356"],"is_preprint":false},{"year":1999,"finding":"ITK associates with PLC-γ1 in a TCR/CD3-regulated manner in T cells; before activation, the Itk SH3 domain mediates constitutive association with PLC-γ1, while after TCR stimulation the Itk SH2 domain dominates the enhanced interaction; the PLC-γ1 SH3 domain (but not PLC-γ1 SH2 domains) contributes to the complex.","method":"Co-immunoprecipitation with domain-specific antibodies and domain deletion mutants in Jurkat and primary T cells","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP with multiple domain mutants, mechanistic model for differential domain usage, single lab","pmids":["10586033"],"is_preprint":false},{"year":1999,"finding":"Itk co-localizes with TCR/CD3 at the membrane upon CD3ε engagement; deletion of the Itk PH domain abolishes membrane association, activation-induced co-localization with TCR, and subsequent tyrosine phosphorylation; replacing the PH domain with an Lck membrane-targeting sequence restores membrane targeting and co-localization but not activation-induced tyrosine phosphorylation, demonstrating the PH domain has an additional function beyond membrane targeting in enabling Itk phosphorylation.","method":"Laser scanning confocal microscopy, PH domain deletion mutants, chimeric membrane-targeted Itk constructs","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging plus domain mutant analysis dissecting PH domain functions, single lab","pmids":["10570288"],"is_preprint":false},{"year":2000,"finding":"Itk PH domain directs constitutive association with buoyant membrane rafts enriched in Lck and LAT; the Itk proline-rich region binds Grb2 and LAT; the Itk SH3 and SH2 domains cooperatively interact with Syk-phosphorylated SLP-76; SLP-76 contains a predicted SH2 binding motif and binds full-length Itk in vitro; kinase-inactive Itk inhibits SLP-76-dependent NFAT activation, implicating multivalent interactions recruiting Itk to LAT-nucleated signaling complexes.","method":"Membrane fractionation, co-immunoprecipitation, SH2/SH3 domain binding assays, in vitro binding, NFAT reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical and cell-based methods in one study, findings replicated by subsequent structural and signaling studies","pmids":["10636929"],"is_preprint":false},{"year":2001,"finding":"Itk SH3 domain interacts with karyopherin α (Rch1α) via its proline-rich motif; TCR-CD3 stimulation increases Itk/Rch1α complex formation and recruits karyopherin β; recombinant Itk (but not Lck, ZAP-70, or Jak3) efficiently phosphorylates Rch1α in vitro; Itk shows constitutive nuclear localization that is upregulated by TCR stimulation or Rch1α overexpression; a Rch1α P242A mutant abolishes the interaction and reduces Itk nuclear localization and TCR-induced IL-2 production.","method":"Co-immunoprecipitation, in vitro kinase assay with GST-fusion proteins, mutagenesis, immunofluorescence subcellular localization, IL-2 production assay","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay plus co-IP plus mutagenesis plus functional readout, single lab","pmids":["11581171"],"is_preprint":false},{"year":2001,"finding":"Noncatalytic domains of Itk contribute to enzymatic activity: deletion of the PH/TH domain reduces catalytic activity ~10-fold; mutation of the proline-rich domain (P158A,P159A) reduces activity ~100-fold; the kinase domain alone is essentially inactive, demonstrating that N-terminal domains are required for efficient catalysis by affecting turnover rate rather than substrate binding.","method":"Recombinant protein expression and purification, steady-state kinetic analysis (kcat, Km), in vitro kinase assay with SAM68 substrate","journal":"Protein expression and purification","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase reconstitution with purified recombinant proteins and quantitative kinetic analysis of multiple domain mutants, single lab","pmids":["11437596"],"is_preprint":false},{"year":2002,"finding":"Cyclophilin A (CypA) inhibits Itk catalytic activity through its peptidyl-prolyl isomerase activity; NMR structural studies show a proline-dependent conformational switch in the Itk SH2 domain regulates substrate recognition and mediates interaction with CypA; CypA and Itk form a stable complex in Jurkat T cells that is disrupted by cyclosporin A; cyclosporin A treatment increases phosphorylation of Itk and its substrate PLC-γ1.","method":"NMR spectroscopy, mutagenesis, co-immunoprecipitation from Jurkat cells, cyclosporin A treatment, phosphorylation Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure with mutagenesis plus cell-based co-IP and pharmacological validation in one study","pmids":["11830645"],"is_preprint":false},{"year":2002,"finding":"Itk is required for efficient NKT cell maturation; Itk-deficient mice have reduced NKT cell numbers with a predominantly immature phenotype, and progressive decrease of NKT cells in older mice, establishing a role for Itk in NKT cell development and peripheral maintenance.","method":"CD1d tetramer staining, flow cytometry, Itk-/- mice","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined phenotypic readout using CD1d tetramers, single lab","pmids":["12193707"],"is_preprint":false},{"year":2002,"finding":"Absence of Itk impairs positive thymic selection at multiple stages but does not affect CD4/CD8 lineage commitment; fewer TCR transgenic T cells develop without Itk, but those that do appear normal in lineage markers.","method":"Itk-/- mice crossed to TCR transgenic lines on multiple MHC backgrounds, flow cytometry","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO in multiple TCR transgenic backgrounds, clear phenotypic readout, single lab","pmids":["12055226"],"is_preprint":false},{"year":2003,"finding":"Itk autophosphorylates at Tyr-180 in the SH3 domain; mutation of either the trans-phosphorylation site (Y511F) or the autophosphorylation site (Y180F) impairs full restoration of cytokine production and ERK activation in Itk-deficient primary T cells; an SH3 point mutant unable to bind ligand also fails to restore function, demonstrating both phosphorylation events and SH3 ligand binding are required for Itk function.","method":"Retroviral transduction of Itk point mutants into Itk-/- primary T cells, cytokine production assay, ERK activation Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple site-specific mutants in primary T cells with functional readouts, mechanistic dissection replicated findings from earlier in vitro work","pmids":["12842872"],"is_preprint":false},{"year":2004,"finding":"Selective small-molecule ITK inhibitors (BMS-488516 and BMS-509744) potently inhibit Itk kinase activity and reduce TCR-induced PLC-γ1 tyrosine phosphorylation, calcium mobilization, IL-2 secretion, and T-cell proliferation in human and mouse cells; BMS-509744 reduces lung inflammation in an ovalbumin mouse asthma model, validating ITK as a target downstream of PLCγ in TCR signaling.","method":"In vitro kinase assay, biochemical T-cell signaling assays (PLCγ1 phosphorylation, calcium flux), IL-2 ELISA, proliferation assay, in vivo mouse asthma model","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with biochemical pathway validation and in vivo model, multiple orthogonal methods, single lab","pmids":["15323564"],"is_preprint":false},{"year":2004,"finding":"Itk signaling promotes Th2 differentiation by negatively regulating T-bet expression; in the absence of skewing cytokines with low-avidity ligands, wild-type T cells preferentially express GATA-3 and become Th2, while Itk-/- T cells produce T-bet and become IFN-γ-producing cells; Itk expression is upregulated during Th2 differentiation while Rlk disappears from Th2 cells.","method":"Itk-/- mice, in vitro T-cell differentiation assays, cytokine measurement, RT-PCR for T-bet and GATA-3","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with mechanistic transcription factor readout, single lab","pmids":["15345221"],"is_preprint":false},{"year":2004,"finding":"ITK is activated by CXCL12/SDF-1α stimulation through CXCR4 via Src and PI3K activities; ITK regulates CXCR4-mediated T-cell migration and adhesion by altering actin polymerization, as ITK-null T cells show defective CXCL12-induced actin polymerization, migration, and adhesion.","method":"Kinase activation assay, Src and PI3K inhibitors, migration assay, adhesion assay, actin polymerization assay in Itk-/- T cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus pharmacological inhibition with multiple functional readouts, single lab","pmids":["15123627"],"is_preprint":false},{"year":2005,"finding":"Itk has a kinase-independent scaffolding function in TCR-induced actin polarization; siRNA-mediated knockdown of Itk or expression of kinase-inactive Itk rescues actin polarization defect; PH domain and SH2 domain mutations abolish this activity; Itk is constitutively associated with Vav and loss of Itk disrupts Vav localization to the immune synapse and Vav-SLP-76 interactions without altering bulk Vav tyrosine phosphorylation; membrane-targeted Vav-CAAX rescues the actin polarization defect.","method":"siRNA knockdown, kinase-dead mutant rescue, confocal microscopy for actin polarization, co-immunoprecipitation, membrane-targeted Vav-CAAX rescue experiment","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (RNAi, kinase-dead mutant, domain mutants, co-IP, rescue with membrane-targeted Vav) in one study, mechanistic dissection of scaffolding vs. catalytic function","pmids":["15661896"],"is_preprint":false},{"year":2006,"finding":"Itk and Rlk deficiency causes CD8+ single-positive thymocytes and peripheral CD8+ T cells to acquire an innate-like phenotype (CD44hi, CD122+, NK1.1+, rapid IFN-γ production, IL-15-dependent, eomesodermin-expressing); expression of a hypersensitive ERK2 mutant partially corrects CD8+ T cell phenotypes in Itk-/- mice, establishing that altered Tec kinase signaling allows development of innate-type CD8+ cells.","method":"Itk-/- and Rlk-/-Itk-/- mice, flow cytometry, cytokine production, hematopoietic chimeras, hypersensitive ERK2 transgene rescue","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with transgenic rescue, multiple phenotypic readouts, replicated simultaneously by another lab (PMID:16860759)","pmids":["16860760","16860759"],"is_preprint":false},{"year":2006,"finding":"The t(5;9)(q33;q22) translocation found in 17% of unspecified PTCL fuses the N-terminal PH domain and proline-rich region of ITK to the tyrosine kinase domain of SYK, creating an ITK-SYK fusion kinase that drives oncogenesis.","method":"Molecular cytogenetics (FISH), RT-PCR, sequencing of breakpoints in patient samples","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — identification of recurrent fusion in 5/30 patient samples with identical breakpoints, molecular characterization of fusion transcript","pmids":["16341044"],"is_preprint":false},{"year":2006,"finding":"Itk forms membrane clusters of at least two molecules within 80 Å upon membrane recruitment via its PH domain; clustering requires PH domain integrity but not the proline-rich region, SH3, SH2 domains, or kinase activity; these clusters form specifically in membrane regions co-occupied by receptors that recruit PI3K.","method":"FRET microscopy, domain deletion mutants, membrane fractionation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET-based localization with domain mutant analysis, single lab","pmids":["17060314"],"is_preprint":false},{"year":2006,"finding":"NMR structure of the Itk SH2 domain bound to a phosphotyrosine peptide reveals that prolyl cis/trans isomerization controls two distinct SH2 conformers; the trans conformer preferentially binds the phosphopeptide; the BG loop in the free trans conformer is pre-arranged for pY+3 contacts; pY binding propagates structural changes to the CD loop and αB helix, providing the structural basis for CypA-regulated conformational switching.","method":"NMR spectroscopy, trans-hydrogen bond scalar coupling analysis, structure determination","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with mechanistic hydrogen-bond coupling analysis, builds on CypA functional study","pmids":["16436281"],"is_preprint":false},{"year":2007,"finding":"SLP-76 is required for TCR-induced tyrosine phosphorylation and activation of ITK (but not ZAP-70); ITK specifically and efficiently phosphorylates PLC-γ1 at Y783 and Y775 in vitro whereas ZAP-70 does not; a fraction of active ITK binds SLP-76 in stimulated cells, and catalytic activity is lost upon mild elution from the SLP-76 complex but restored upon reconstitution, establishing that ongoing SLP-76 association is required to maintain ITK in an active conformation.","method":"In vitro kinase assay with recombinant proteins (ITK vs ZAP-70 side-by-side), co-immunoprecipitation from TCR-stimulated cells, complex elution and reconstitution, SLP-76 mutant analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase reconstitution identifying direct substrates plus mechanistic complex reconstitution/dissociation experiments, multiple orthogonal methods in one rigorous study","pmids":["17420479"],"is_preprint":false},{"year":2007,"finding":"Itk differentially regulates distinct NK cell-activating pathways in a catalytic-activity-dependent manner: enhanced Itk expression increases calcium mobilization, granule release, and cytotoxicity via the ITAM-containing FcR, but decreases cytotoxicity and granule release downstream of the NKG2D receptor; a kinase-dead Itk mutant abolishes both effects.","method":"Itk overexpression and knockdown in human NK cells, cytotoxicity assays, calcium flux, granule release assay, kinase-dead mutant","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with kinase-dead mutant, multiple functional readouts, single lab","pmids":["17339454"],"is_preprint":false},{"year":2008,"finding":"Loss of ITK function (via ITK-specific siRNA, kinase-inactive mutant, or ITK inhibitor) markedly reduces intracellular HIV p24 levels; ITK inhibition partially blocks HIV viral entry (correlating with decreased actin polarization to gp120) and reduces HIV transcription; overexpression of ITK increases viral transcription and virus-like particle formation; ITK does not affect CD4 or CXCR4 expression.","method":"siRNA knockdown, kinase-inactive ITK mutant, ITK inhibitor, HIV infection assay, p24 ELISA, actin polarization imaging, viral transcription assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — three complementary loss-of-function approaches with multiple mechanistic readouts, single lab","pmids":["18443296"],"is_preprint":false},{"year":2009,"finding":"NMR structure of the binary Itk SH3/SH2 complex reveals a nonclassical interaction independent of phosphotyrosine motifs and proline-rich sequences; the higher-affinity cis SH2 conformer (controlled by prolyl isomerization) is preorganized to form a hydrophobic interface with the SH3 domain; autophosphorylation in the Itk SH3 domain is predicted to increase intermolecular SH3/SH2 affinity.","method":"NMR spectroscopy, structure determination of SH3/SH2 binary complex","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure determination revealing nonclassical domain-domain interaction mechanism, mechanistic insight built on prior structural and biochemical studies","pmids":["19361414"],"is_preprint":false},{"year":2009,"finding":"Itk phosphorylation and activation of PLC-γ1 requires a direct phosphotyrosine-independent docking interaction between the Itk kinase domain and the nSH2 domain of PLC-γ1; disruption of this docking interface by mutagenesis attenuates T-cell signaling.","method":"NMR spectroscopy, mutagenesis of docking interface, T-cell signaling assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR-defined docking interface with mutagenesis validated by T-cell functional assay, single lab","pmids":["19955438"],"is_preprint":false},{"year":2009,"finding":"Itk signaling in γδ T cells controls IgE production in vivo; Itk-/- γδ T cells produce high levels of Th2 cytokines when stimulated through the γδ TCR; Itk-/-Tcrd-/- mice have normal IgE levels; activated Itk-/- γδ T cells upregulate costimulatory molecules for B cell help; increased Vγ1.1+Vδ6.3+ γδ NKT cells with increased PLZF expression are found in Itk-/- mice.","method":"Itk-/- and Itk-/-Tcrd-/- mice, serum IgE measurement, γδ T cell isolation and stimulation, cytokine assay, flow cytometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — double-KO genetic epistasis establishing γδ T cell-specific mechanism for IgE dysregulation, multiple readouts, single lab","pmids":["19416854"],"is_preprint":false},{"year":2010,"finding":"ITK-SYK fusion kinase constitutively associates with lipid rafts in T cells and triggers antigen-independent phosphorylation of TCR-proximal signaling proteins, leading to activation of downstream pathways that mimic regular TCR ligation (CD69 upregulation, IL-2 production in vitro, thymocyte deletion and T-cell activation in vivo); conditional expression in mice induces highly malignant PTCL with 100% penetrance.","method":"Lipid raft fractionation, phosphorylation assays, in vitro T-cell activation assays, conditional transgenic mouse model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic dissection of fusion kinase signaling with both in vitro and in vivo confirmation, 100% penetrant disease model, replicated by second group (PMID:20670954)","pmids":["20439541"],"is_preprint":false},{"year":2010,"finding":"ITK-SYK-induced T-cell lymphoproliferative disease in mice requires SYK kinase activity; membrane localization of ITK-SYK via its PH domain is not required for disease development (PH domain R29C mutant enhances rather than abolishes disease); CBL binding to membrane-associated ITK-SYK (E42K mutant) delays disease development.","method":"Bone marrow transplantation model, SYK kinase inhibitor treatment, point mutants (R29C, E42K) in mouse disease model","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mouse model with pharmacological inhibition and defined point mutants, single lab","pmids":["20670954"],"is_preprint":false},{"year":2011,"finding":"Loss of Itk alters the spatiotemporal distribution of 14 of 16 signaling sensors at the T cell–APC interface; Cdc42 activation at the center of the interface is impaired (total active Cdc42 unchanged); reconstitution with interface-targeted active Cdc42 restores actin accumulation in Itk-/- T cells; Itk controls central localization of SLAT, which contributes to Cdc42 activation at the interface.","method":"Live-cell imaging with signaling biosensors/sensors, Itk-/- mice, targeted active Cdc42 rescue construct, confocal microscopy","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic spatiotemporal imaging of 16 sensors plus mechanistic rescue experiment, multiple orthogonal methods","pmids":["21971040"],"is_preprint":false},{"year":2011,"finding":"Itk and Btk double-knockout mast cells show severely impaired FcεRI-induced degranulation and cytokine secretion, with significant reduction in PLC-γ2 phosphorylation, impaired calcium responses, and altered NFAT1 nuclear localization; network analysis suggests Itk plays both positive and negative roles while Btk primarily plays a positive role in mast cell FcεRI cytokine secretion.","method":"Itk/Btk double-KO mice, BMMC generation, degranulation assay, cytokine ELISA, calcium flux, PLC-γ2 phosphorylation Western blot, NFAT1 nuclear localization imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-KO with multiple orthogonal biochemical readouts, mechanistic dissection of Itk vs Btk contributions","pmids":["21212279"],"is_preprint":false},{"year":2012,"finding":"The Itk PH domain binds most prominently to phosphatidylinositol monophosphates (PI(3)P, PI(4)P, PI(5)P) and to a lesser extent to PIP2 and PIP3; an ITK R29H patient mutation (in the PH domain) dramatically reduces these phosphoinositide interactions, abolishes rescue of calcium flux in Itk-/- T cells, and reduces protein half-life.","method":"Lipid binding assay (phosphoinositide strips/liposome binding), calcium flux rescue assay in Itk-/- T cells, pulse-chase protein stability assay","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct lipid binding assay plus functional rescue plus protein stability measurement in one study, single lab","pmids":["22289921"],"is_preprint":false},{"year":2012,"finding":"ITK signaling promotes IRF4 upregulation in CD8+ T cells following TCR stimulation; ITK inhibitor treatment impairs IRF4 induction; in IRF4-deficient CD8+ T cells, TCR activation leads to rapid Eomesodermin upregulation (further enhanced by IL-4), establishing that ITK-IRF4 signaling normally suppresses Eomes and regulates conventional vs innate CD8+ T-cell fate.","method":"Small-molecule ITK inhibitor, IRF4-knockout mice, ITK inhibitor treatment, flow cytometry and RT-PCR for IRF4 and Eomes expression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological ITK inhibition and genetic IRF4 KO with mechanistic transcription factor readouts, single lab","pmids":["23011795"],"is_preprint":false},{"year":2013,"finding":"Ibrutinib irreversibly inhibits ITK in T cells (in addition to BTK in B cells); ibrutinib treatment drives a Th1-selective pressure by ablating Th2 immunity; ITK is confirmed as a covalent irreversible target of ibrutinib in T cells using clinical trial samples and disease models.","method":"In silico docking, biochemical kinase assays, molecular analysis of T cells from ibrutinib clinical trial patients, Leishmania and Listeria infection models","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical confirmation of irreversible ITK inhibition combined with clinical patient samples and multiple in vivo disease models","pmids":["23886836"],"is_preprint":false},{"year":2013,"finding":"CD28 and ITK signals regulate autoreactive T-cell trafficking to tissues; loss of ITK in Ctla4-/- mice does not block T-cell activation but causes self-reactive T cells to accumulate in secondary lymphoid organs instead of entering tissues; ITK inhibitors phenocopy the null mutant and prevent pancreatic islet infiltration by diabetogenic T cells.","method":"Itk-/-;Ctla4-/- double-knockout mice, adoptive transfer, ITK inhibitor treatment in type 1 diabetes mouse model, tissue histology","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-KO genetic epistasis plus pharmacological inhibition with in vivo tissue trafficking readout, two complementary approaches","pmids":["24270545"],"is_preprint":false},{"year":2014,"finding":"Itk deficiency increases sensitivity to IL-2 signaling and skews CD4+ T-cell differentiation toward Foxp3+ Treg cells; Itk-/- T cells show reduced TCR-induced mTOR target phosphorylation and impaired mTOR activation by IL-2; TCR stimulation normally represses Pten in a dose-dependent manner, but in the absence of Itk, Pten is not repressed, uncoupling STAT5 and PI3K signaling; Itk-deficient cells show impaired TCR-mediated induction of Myc and miR-19b (known Pten repressors).","method":"Itk-/- mice, in vitro Th17/Treg differentiation, mTOR target phosphorylation (S6K, 4EBP1), STAT5 phosphorylation, Pten expression, Myc/miR-19b expression, in vivo Treg development","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical measurements with genetic KO establishing mechanistic pathway (ITK→mTOR/PI3K→Pten→Treg/Th17 balance), single lab with extensive controls","pmids":["24534190"],"is_preprint":false},{"year":2015,"finding":"PRN694 covalently binds to Cys442 of ITK (and Cys350 of RLK) in the kinase domain, blocking kinase activity with extended target residence time; it prevents TCR- and Fc receptor-induced cellular activation, inhibits T-cell proliferation, blocks proinflammatory cytokine release, inhibits Th17 cell activation, and shows in vivo pharmacodynamic effects reducing delayed-type hypersensitivity.","method":"Molecular modeling, biochemical kinase assay, cysteine-targeting covalent binding characterization, in vitro T-cell functional assays, ex vivo T-PLL cell assays, in vivo DTH model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — molecular modeling plus biochemical covalent binding characterization plus multiple functional assays in vitro and in vivo, single lab","pmids":["25593320"],"is_preprint":false},{"year":2016,"finding":"Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4; Itk-/- CD4+ T cells under Th9 conditions fail to produce IL-9 and have reduced IRF4 levels; IL-9 and IRF4 expression are rescued by exogenous IL-2 or constitutively active STAT5 but not NFATc1; STAT5 binds the Irf4 promoter; Itk inhibition also reduces IL-9 expression in human T cells.","method":"Itk-/- mice, Th9 in vitro differentiation, cytokine measurement, STAT5 ChIP at Irf4 promoter, constitutively active STAT5 rescue, ITK inhibitor in human T cells, mouse asthma model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus ChIP plus rescue experiments plus pharmacological inhibition in human cells, multiple orthogonal methods, replicated in vivo","pmids":["26936133"],"is_preprint":false},{"year":2016,"finding":"TCR signaling activates an ITK-NF-κB-GATA-3 axis that promotes chemotherapy resistance in T-cell lymphomas; pharmacological inhibition of ITK prevents activation of this signaling axis and overcomes chemotherapy resistance.","method":"Genetic and pharmacological inhibition of ITK in primary T-cell lymphoma cells and patient-derived cell lines, NF-κB and GATA-3 activation assays, chemotherapy resistance assays","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological approaches in patient-derived cells with defined pathway readout, single lab","pmids":["27780854"],"is_preprint":false},{"year":2017,"finding":"ITK signaling through the Ras/IRF4 pathway is required for functional Tr1 cell development; ITK kinase activity is required for mouse and human Tr1 differentiation; expression of constitutively active HRas rescues IRF4 expression and Tr1 differentiation in Itk-/- cells; IRF4 expression also rescues Tr1 suppressive function in Itk-/- cells.","method":"Itk-/- mice, in vitro and in vivo Tr1 differentiation, constitutively active HRas rescue, IRF4 rescue, ITK kinase inhibitor in human T cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus constitutively active Ras rescue plus IRF4 rescue plus human cell pharmacological validation, multiple orthogonal approaches","pmids":["28635957"],"is_preprint":false},{"year":2021,"finding":"ITK preferentially aids NF-κB activation downstream of the TCR; NF-κB shows dynamic graded activation in response to TCR signal strength that is dampened by ITK inhibitor; ITK inhibitor-treated cells show reduced AP-1 factors (Fos, Fosb), NF-κB response gene transcripts, and IL-2 transcripts; ATAC-seq shows ITK-sensitive genomic regions are enriched for NF-κB and AP-1 motifs; NFAT1 and Erk1/2 activation is digital and less sensitive to ITK inhibition.","method":"ITK inhibitor treatment, single-cell nuclear NFAT1/NF-κB/Erk1/2 imaging, ATAC-seq, gene expression analysis in naïve CD8+ OT-I cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — pharmacological ITK inhibition with single-cell imaging of transcription factor activation plus genome-wide chromatin accessibility and transcriptomics, multiple orthogonal methods","pmids":["34452995"],"is_preprint":false},{"year":2024,"finding":"TNF-α released by activated human naïve CD4+ T cells stimulates metabolic reprogramming (increased glycolysis, amino acid uptake, glutamine oxidation, mitochondrial biogenesis) through ITK-mediated activation of Akt-mTOR signaling, independently of NF-κB; TNF-α also drives Th1 and Th17 but not Treg differentiation via this ITK-Akt-mTOR axis.","method":"Human naïve CD4+ T-cell activation assays, ITK inhibitor, Akt phosphorylation measurement, metabolic flux analysis, T-cell differentiation assays, RA patient samples","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological ITK inhibition with metabolic and signaling readouts in primary human cells, NF-κB pathway ruled out, single lab","pmids":["38652761"],"is_preprint":false}],"current_model":"ITK is a Tec-family non-receptor tyrosine kinase expressed predominantly in T cells that is activated downstream of the TCR (and CD28/CD2/CXCR4/FcεRI) via a sequential mechanism: PI3K generates PIP3 that recruits ITK to the plasma membrane via its PH domain; Lck then trans-phosphorylates the activation loop at Tyr-511 to activate ITK; SLP-76 association (via ITK SH3/SH2 domains) is required to maintain ITK in an active conformation; active ITK directly phosphorylates PLC-γ1 at Y783/Y775 through a docking interaction between the ITK kinase domain and the PLC-γ1 nSH2 domain, driving IP3 production, calcium influx, and downstream NFAT/NF-κB/AP-1 activation; ITK also performs kinase-independent scaffolding functions (through its PH, SH2 domains) to localize Vav to the immune synapse for actin polarization; ITK activity is negatively regulated by cyclophilin A-mediated prolyl isomerization of its SH2 domain, while autophosphorylation at Tyr-180 in the SH3 domain provides an additional regulatory layer; in vivo, ITK is required for positive thymic selection, Th2/Th9/Tr1 differentiation, NKT cell maturation, and conventional CD8+ T-cell development, while its absence promotes innate-like T-cell phenotypes and Treg/Th1 skewing via altered mTOR-Pten-IRF4 signaling."},"narrative":{"mechanistic_narrative":"ITK is a T-cell-lineage-restricted, IL-2-inducible Tec-family non-receptor tyrosine kinase that couples antigen-receptor engagement to phospholipase C-γ1 activation, calcium flux, and downstream transcriptional programs governing T-cell development and effector differentiation [PMID:1280821, PMID:9584150]. Activation proceeds by sequential, domain-coordinated steps: PI3-kinase-dependent membrane recruitment through the ITK pleckstrin-homology domain — which binds D3-phosphorylated phosphoinositides and drives membrane clustering — positions ITK at receptor-proximal sites, and this PH-domain function is the critical step in Src/Lck-induced activation [PMID:9326591, PMID:17060314, PMID:22289921]. Lck then directly trans-phosphorylates the activation-loop residue Tyr-511, an event required for catalytic activity, while autophosphorylation at Tyr-180 in the SH3 domain and ligand binding by the SH3 domain provide additional layers of regulation [PMID:9312162, PMID:12842872]. ITK is recruited into LAT/SLP-76-nucleated signaling complexes through cooperative SH3/SH2 and proline-rich interactions, and ongoing SLP-76 association is required to maintain ITK in an active conformation [PMID:10636929, PMID:17420479]. Active ITK selectively phosphorylates PLC-γ1 at Y775/Y783 via a direct, phosphotyrosine-independent docking interaction between the ITK kinase domain and the PLC-γ1 nSH2 domain, driving IP3 production and capacitative calcium entry that ZAP-70 cannot supply [PMID:17420479, PMID:19955438, PMID:9584150]. Catalytic output is restrained by cyclophilin A, whose prolyl-isomerase activity exploits a cis/trans conformational switch in the ITK SH2 domain to inhibit kinase activity and modulate substrate recognition [PMID:11830645, PMID:16436281]. Beyond its catalytic role, ITK performs a kinase-independent scaffolding function via its PH and SH2 domains to localize Vav to the immune synapse and organize Cdc42-dependent actin polarization at the T-cell–APC interface [PMID:15661896, PMID:21971040]. Genetically, ITK is required for proximal TCR signaling, positive thymic selection, NKT cell maturation, and Th2/Th9/Tr1 differentiation, and shapes the conventional-versus-innate CD8+ T-cell fate decision through an mTOR/Pten and IRF4/Eomes axis; its loss promotes innate-like T cells and Treg/Th1 skewing [PMID:8777721, PMID:12055226, PMID:12193707, PMID:15345221, PMID:24534190, PMID:23011795, PMID:28635957]. A recurrent t(5;9) translocation fuses the ITK PH and proline-rich region to the SYK kinase domain, generating a constitutively active fusion kinase that drives peripheral T-cell lymphoma [PMID:16341044, PMID:20439541], and ITK is a covalent off-target of the BTK inhibitor ibrutinib [PMID:23886836].","teleology":[{"year":1992,"claim":"Establishing ITK's identity answered whether a dedicated, lineage-restricted tyrosine kinase exists in T cells, defining it as an IL-2-inducible enzyme of the T-cell compartment.","evidence":"Molecular cloning and Northern blot of mouse tissues and cell lines","pmids":["1280821"],"confidence":"Medium","gaps":["No functional or signaling role defined","No domain mechanism established"]},{"year":1995,"claim":"Knockout mice answered whether ITK is functionally required, placing it in proximal TCR signaling rather than the distal PMA/ionomycin or IL-2 pathways.","evidence":"Gene targeting, flow cytometry, proliferation assays with TCR/MHC versus PMA+ionomycin/IL-2 stimulation","pmids":["8777721"],"confidence":"High","gaps":["Molecular substrate not identified","Step in the TCR cascade not pinpointed"]},{"year":1997,"claim":"In vitro reconstitution answered how ITK is switched on, showing Lck directly phosphorylates the activation-loop Tyr-511, and that PI3K-dependent PH-domain membrane recruitment is the critical upstream step.","evidence":"Baculovirus recombinant kinase assays with Y511F mutagenesis; PH-domain deletion and membrane-targeting rescue with PI3K inhibitors","pmids":["9312162","9326591"],"confidence":"High","gaps":["PH domain has a function beyond membrane targeting that was undefined at the time","Direct physiological substrate not yet established"]},{"year":1998,"claim":"Biochemical dissection in knockout T cells answered where ITK acts in the cascade, showing it lies downstream of/parallel to ZAP-70 and is required for IP3 generation, PLC-γ1 phosphorylation, and capacitative calcium entry.","evidence":"Calcium flux (fura-2), IP3 measurement, phosphotyrosine blots, thapsigargin in Itk-/- T cells","pmids":["9584150"],"confidence":"High","gaps":["Direct versus indirect PLC-γ1 phosphorylation not resolved","Recruitment mechanism into the signaling complex unknown"]},{"year":1999,"claim":"Genetic epistasis with Rlk and adaptor/PLC-γ1 association studies answered how ITK is wired into the TCR complex, establishing Tec kinases as critical PLC-γ regulators recruited via SH3/SH2 domains.","evidence":"Rlk/Itk double-knockout mice with IP3/calcium/ERK readouts and in vivo infection; co-IP with PLC-γ1 domain mutants; RIBP yeast two-hybrid and knockout","pmids":["10213685","10586033","10587356"],"confidence":"High","gaps":["Direct kinase-substrate relationship with PLC-γ1 not yet proven in vitro","Docking interface unmapped"]},{"year":2000,"claim":"Mapping ITK's multivalent interactions answered how it is concentrated at the membrane, showing PH-domain raft targeting plus cooperative SH3/SH2 engagement of Syk-phosphorylated SLP-76 and proline-rich binding to Grb2/LAT.","evidence":"Membrane fractionation, co-IP, SH2/SH3 binding assays, NFAT reporter with kinase-dead ITK","pmids":["10636929"],"confidence":"High","gaps":["Whether SLP-76 binding regulates catalytic state not yet shown","Stoichiometry of the complex undefined"]},{"year":2002,"claim":"Structural and biochemical work answered how ITK catalytic activity is restrained, identifying cyclophilin A prolyl-isomerase-driven cis/trans switching of the SH2 domain as a negative regulator.","evidence":"NMR of the SH2 domain, mutagenesis, co-IP from Jurkat cells, cyclosporin A treatment with phospho-PLC-γ1 readout","pmids":["11830645","16436281"],"confidence":"High","gaps":["Physiological trigger for CypA engagement in vivo not defined","Quantitative contribution to overall ITK output unclear"]},{"year":2003,"claim":"Mutational reconstitution in primary T cells answered which regulatory events are functionally required, showing both Tyr-511 trans-phosphorylation, Tyr-180 SH3 autophosphorylation, and SH3 ligand binding are each needed for full function.","evidence":"Retroviral transduction of Itk point mutants into Itk-/- T cells with cytokine and ERK readouts","pmids":["12842872"],"confidence":"High","gaps":["SH3 ligand identity in vivo not pinned down","Order of phosphorylation events not resolved"]},{"year":2005,"claim":"Separation-of-function experiments answered whether ITK has roles beyond catalysis, defining a kinase-independent scaffolding function that localizes Vav to drive actin polarization.","evidence":"siRNA, kinase-dead and PH/SH2 domain mutants, co-IP, confocal actin imaging, membrane-targeted Vav-CAAX rescue","pmids":["15661896"],"confidence":"High","gaps":["How Vav is held by ITK structurally undefined","Relationship to catalytic signaling at the synapse unclear"]},{"year":2007,"claim":"Side-by-side in vitro kinase reconstitution answered whether ITK directly phosphorylates PLC-γ1, identifying Y775/Y783 as specific ITK (not ZAP-70) sites and showing SLP-76 association maintains the active conformation.","evidence":"Recombinant ITK vs ZAP-70 kinase assays, co-IP, complex elution/reconstitution, SLP-76 mutants","pmids":["17420479"],"confidence":"High","gaps":["Structural basis of substrate selectivity not yet defined","Mechanism of conformational maintenance by SLP-76 unresolved"]},{"year":2009,"claim":"NMR structures answered how ITK domains coordinate substrate engagement, revealing a nonclassical SH3/SH2 interface tuned by prolyl isomerization and a phosphotyrosine-independent kinase-domain docking onto the PLC-γ1 nSH2 domain.","evidence":"NMR structure determination of the SH3/SH2 binary complex and of the ITK-PLC-γ1 docking interface with mutagenesis and T-cell signaling assays","pmids":["19361414","19955438"],"confidence":"High","gaps":["Full-length autoinhibited architecture not solved","Allosteric coupling between domains in vivo not quantified"]},{"year":2006,"claim":"Phenotypic and genetic-rescue studies answered how ITK governs CD8 T-cell identity, showing Tec kinase loss yields innate-like CD8+ cells correctable by enhanced ERK signaling.","evidence":"Itk-/- and Rlk-/-Itk-/- mice, chimeras, hypersensitive ERK2 transgene rescue; NKT and thymic selection phenotyping","pmids":["16860760","12193707","12055226"],"confidence":"High","gaps":["Transcriptional effectors not yet identified at this stage","Cell-intrinsic versus -extrinsic contributions partly unresolved"]},{"year":2012,"claim":"Transcription-factor and pathway analyses answered how ITK signal strength is decoded into fate, linking ITK to IRF4 induction and Eomes suppression and to PH-domain phosphoinositide binding affected by a patient mutation.","evidence":"ITK inhibitor and IRF4-knockout mice for Eomes readout; lipid binding assays, calcium-rescue, and protein stability for the R29H PH-domain mutation","pmids":["23011795","22289921"],"confidence":"Medium","gaps":["Direct ITK targets upstream of IRF4 not mapped","Clinical genotype-phenotype correlation limited"]},{"year":2014,"claim":"Mechanistic pathway dissection answered how ITK biases CD4 differentiation, showing ITK loss derepresses Pten and dampens mTOR, skewing toward Foxp3+ Treg, and that ITK promotes Th9/Tr1 via IL-2/STAT5/IRF4 and Ras/IRF4 axes.","evidence":"Itk-/- mice with mTOR/STAT5/Pten/Myc readouts; STAT5 ChIP at Irf4, constitutively active STAT5 and HRas rescue, ITK inhibitor in human cells","pmids":["24534190","26936133","28635957"],"confidence":"High","gaps":["Direct ITK substrates linking to Pten/Myc not identified","Hierarchy among parallel differentiation axes unclear"]},{"year":2021,"claim":"Single-cell and genome-wide analyses answered which transcriptional outputs ITK preferentially tunes, showing ITK shapes graded NF-κB and AP-1 activation while NFAT1/ERK responses are more digital and ITK-insensitive.","evidence":"ITK inhibitor with single-cell NFAT1/NF-κB/ERK imaging, ATAC-seq, transcriptomics in naïve CD8+ OT-I cells; earlier CD2/IL-2 promoter and NFAT reporter work","pmids":["34452995","9130632"],"confidence":"High","gaps":["Direct molecular link from ITK to NF-κB/AP-1 not fully mapped","Generalizability across T-cell subsets untested"]},{"year":2010,"claim":"Characterization of the ITK-SYK fusion answered how ITK contributes to lymphomagenesis, showing the fusion constitutively activates TCR-proximal signaling and drives fully penetrant peripheral T-cell lymphoma requiring SYK activity.","evidence":"Cytogenetics/RT-PCR in patient samples; lipid raft fractionation, in vitro activation assays, conditional transgenic and bone-marrow transplant mouse models with R29C/E42K mutants and SYK inhibition","pmids":["16341044","20439541","20670954"],"confidence":"High","gaps":["Contribution of native ITK (versus fusion) to lymphoma unclear","Membrane-localization requirement context-dependent"]},{"year":2015,"claim":"Inhibitor and pharmacology studies answered whether ITK is a tractable drug target, defining covalent active-site cysteines, ibrutinib off-target inhibition, and in vivo immunomodulatory and trafficking effects.","evidence":"Selective and covalent inhibitors (BMS-509744, PRN694 targeting Cys442), ibrutinib clinical samples and infection models; Itk-/-;Ctla4-/- trafficking studies","pmids":["25593320","23886836","15323564","24270545"],"confidence":"High","gaps":["Long-term immune consequences of chronic ITK inhibition undefined","Selectivity over other Tec kinases incomplete"]},{"year":2024,"claim":"Metabolic profiling answered how ITK couples cytokine cues to T-cell metabolism, showing TNF-α drives glycolytic/mitochondrial reprogramming and Th1/Th17 bias through ITK-Akt-mTOR independently of NF-κB.","evidence":"ITK inhibitor in human naïve CD4+ T cells, Akt phosphorylation, metabolic flux analysis, differentiation assays, RA patient samples","pmids":["38652761"],"confidence":"Medium","gaps":["Direct ITK substrate in the Akt-mTOR arm not identified","In vivo relevance of the TNF-ITK-mTOR axis untested"]},{"year":null,"claim":"How ITK's catalytic and kinase-independent scaffolding functions are integrated within a single full-length autoregulated molecule at the immune synapse, and which direct substrates link ITK to the NF-κB/AP-1 and Pten/mTOR programs, remain open.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length autoinhibited structure","Direct substrates beyond PLC-γ1 largely uncatalogued","Mechanism linking ITK activity to NF-κB and Pten regulation unmapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[7,32,36]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[7,32,18,19]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[8,42,30]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[27,17]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[27,40]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,16,17,30]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[18]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,12,13,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,32,36,51]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,22,25,28,46]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[29,38,49]}],"complexes":["LAT/SLP-76 signalosome"],"partners":["LCK","SLP-76","PLCG1","VAV1","CD28","GRB2","LAT","PPIA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q08881","full_name":"Tyrosine-protein kinase ITK/TSK","aliases":["Interleukin-2-inducible T-cell kinase","IL-2-inducible T-cell kinase","Kinase EMT","T-cell-specific kinase","Tyrosine-protein kinase Lyk"],"length_aa":620,"mass_kda":71.8,"function":"Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activation. Once activated, phosphorylates PLCG1, leading to the activation of this lipase and subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. Phosphorylates 2 essential adapter proteins: the linker for activation of T-cells/LAT protein and LCP2. Then, a large number of signaling molecules such as VAV1 are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation (PubMed:12186560, PubMed:12682224, PubMed:21725281). Required for TCR-mediated calcium response in gamma-delta T-cells, may also be involved in the modulation of the transcriptomic signature in the Vgamma2-positive subset of immature gamma-delta T-cells (By similarity). Phosphorylates TBX21 at 'Tyr-530' and mediates its interaction with GATA3 (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q08881/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ITK","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ITK","total_profiled":1310},"omim":[{"mim_id":"615758","title":"IMMUNODEFICIENCY 22; IMD22","url":"https://www.omim.org/entry/615758"},{"mim_id":"613011","title":"LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1","url":"https://www.omim.org/entry/613011"},{"mim_id":"608232","title":"LEUKEMIA, CHRONIC MYELOID; CML","url":"https://www.omim.org/entry/608232"},{"mim_id":"607762","title":"KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 2; KIRREL2","url":"https://www.omim.org/entry/607762"},{"mim_id":"607761","title":"KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 3; KIRREL3","url":"https://www.omim.org/entry/607761"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":53.6}],"url":"https://www.proteinatlas.org/search/ITK"},"hgnc":{"alias_symbol":["EMT","PSCTK2","LYK"],"prev_symbol":[]},"alphafold":{"accession":"Q08881","domains":[{"cath_id":"2.30.29.30","chopping":"6-146","consensus_level":"high","plddt":88.4175,"start":6,"end":146},{"cath_id":"2.30.30.40","chopping":"176-229","consensus_level":"high","plddt":88.453,"start":176,"end":229},{"cath_id":"3.30.505.10","chopping":"241-338","consensus_level":"high","plddt":84.6316,"start":241,"end":338},{"cath_id":"3.30.200.20","chopping":"361-437","consensus_level":"high","plddt":82.9173,"start":361,"end":437},{"cath_id":"1.10.510.10","chopping":"442-619","consensus_level":"high","plddt":89.5729,"start":442,"end":619}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q08881","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q08881-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q08881-F1-predicted_aligned_error_v6.png","plddt_mean":84.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ITK","jax_strain_url":"https://www.jax.org/strain/search?query=ITK"},"sequence":{"accession":"Q08881","fasta_url":"https://rest.uniprot.org/uniprotkb/Q08881.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q08881/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q08881"}},"corpus_meta":[{"pmid":"23886836","id":"PMC_23886836","title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23886836","citation_count":690,"is_preprint":false},{"pmid":"10213685","id":"PMC_10213685","title":"Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10213685","citation_count":311,"is_preprint":false},{"pmid":"1280821","id":"PMC_1280821","title":"itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1280821","citation_count":255,"is_preprint":false},{"pmid":"9584150","id":"PMC_9584150","title":"T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9584150","citation_count":254,"is_preprint":false},{"pmid":"8777721","id":"PMC_8777721","title":"Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk.","date":"1995","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/8777721","citation_count":253,"is_preprint":false},{"pmid":"11340625","id":"PMC_11340625","title":"The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species.","date":"2001","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11340625","citation_count":238,"is_preprint":false},{"pmid":"11830645","id":"PMC_11830645","title":"Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11830645","citation_count":234,"is_preprint":false},{"pmid":"10636929","id":"PMC_10636929","title":"Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10636929","citation_count":215,"is_preprint":false},{"pmid":"20519342","id":"PMC_20519342","title":"T-cell signaling regulated by the Tec family kinase, Itk.","date":"2010","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/20519342","citation_count":214,"is_preprint":false},{"pmid":"7524075","id":"PMC_7524075","title":"CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7524075","citation_count":213,"is_preprint":false},{"pmid":"16341044","id":"PMC_16341044","title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.","date":"2006","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/16341044","citation_count":201,"is_preprint":false},{"pmid":"7970727","id":"PMC_7970727","title":"BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2.","date":"1994","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7970727","citation_count":171,"is_preprint":false},{"pmid":"24534190","id":"PMC_24534190","title":"Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24534190","citation_count":163,"is_preprint":false},{"pmid":"16860760","id":"PMC_16860760","title":"Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk.","date":"2006","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16860760","citation_count":159,"is_preprint":false},{"pmid":"7568038","id":"PMC_7568038","title":"p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7568038","citation_count":158,"is_preprint":false},{"pmid":"16860759","id":"PMC_16860759","title":"The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells.","date":"2006","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16860759","citation_count":154,"is_preprint":false},{"pmid":"8810341","id":"PMC_8810341","title":"Identification of Itk/Tsk Src homology 3 domain ligands.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8810341","citation_count":150,"is_preprint":false},{"pmid":"9326591","id":"PMC_9326591","title":"Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9326591","citation_count":146,"is_preprint":false},{"pmid":"15345221","id":"PMC_15345221","title":"Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet.","date":"2004","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15345221","citation_count":138,"is_preprint":false},{"pmid":"9312162","id":"PMC_9312162","title":"Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9312162","citation_count":138,"is_preprint":false},{"pmid":"20439541","id":"PMC_20439541","title":"The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20439541","citation_count":120,"is_preprint":false},{"pmid":"12193707","id":"PMC_12193707","title":"NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12193707","citation_count":117,"is_preprint":false},{"pmid":"19416854","id":"PMC_19416854","title":"Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivo.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19416854","citation_count":113,"is_preprint":false},{"pmid":"19290923","id":"PMC_19290923","title":"Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk.","date":"2009","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/19290923","citation_count":112,"is_preprint":false},{"pmid":"15661896","id":"PMC_15661896","title":"Kinase-independent functions for Itk in TCR-induced regulation of Vav and the actin cytoskeleton.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15661896","citation_count":108,"is_preprint":false},{"pmid":"22289921","id":"PMC_22289921","title":"Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.","date":"2012","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/22289921","citation_count":100,"is_preprint":false},{"pmid":"15323564","id":"PMC_15323564","title":"Selective Itk inhibitors block T-cell activation and murine lung inflammation.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15323564","citation_count":98,"is_preprint":false},{"pmid":"18292523","id":"PMC_18292523","title":"The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18292523","citation_count":94,"is_preprint":false},{"pmid":"23011795","id":"PMC_23011795","title":"TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23011795","citation_count":83,"is_preprint":false},{"pmid":"7561053","id":"PMC_7561053","title":"Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on Fc epsilon RI cross-linking on mast cells.","date":"1995","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7561053","citation_count":83,"is_preprint":false},{"pmid":"25339095","id":"PMC_25339095","title":"Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects.","date":"2014","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25339095","citation_count":82,"is_preprint":false},{"pmid":"26348529","id":"PMC_26348529","title":"Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26348529","citation_count":80,"is_preprint":false},{"pmid":"26936133","id":"PMC_26936133","title":"Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26936133","citation_count":79,"is_preprint":false},{"pmid":"17339454","id":"PMC_17339454","title":"Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17339454","citation_count":75,"is_preprint":false},{"pmid":"14993283","id":"PMC_14993283","title":"Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14993283","citation_count":73,"is_preprint":false},{"pmid":"17420479","id":"PMC_17420479","title":"SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17420479","citation_count":73,"is_preprint":false},{"pmid":"10587356","id":"PMC_10587356","title":"RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation.","date":"1999","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10587356","citation_count":72,"is_preprint":false},{"pmid":"16880398","id":"PMC_16880398","title":"ITK and IL-15 support two distinct subsets of CD8+ T cells.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16880398","citation_count":72,"is_preprint":false},{"pmid":"28635957","id":"PMC_28635957","title":"ITK signalling via the Ras/IRF4 pathway regulates the development and function of Tr1 cells.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28635957","citation_count":65,"is_preprint":false},{"pmid":"12842872","id":"PMC_12842872","title":"Itk phosphorylation sites are required for functional activity in primary T cells.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12842872","citation_count":65,"is_preprint":false},{"pmid":"19290924","id":"PMC_19290924","title":"The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development.","date":"2009","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/19290924","citation_count":64,"is_preprint":false},{"pmid":"15123627","id":"PMC_15123627","title":"Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase ITK.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15123627","citation_count":64,"is_preprint":false},{"pmid":"21362139","id":"PMC_21362139","title":"Tec family kinases Itk and Rlk / Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates.","date":"2011","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/21362139","citation_count":63,"is_preprint":false},{"pmid":"23672610","id":"PMC_23672610","title":"Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases.","date":"2013","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23672610","citation_count":60,"is_preprint":false},{"pmid":"18443296","id":"PMC_18443296","title":"Selective targeting of ITK blocks multiple steps of HIV replication.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18443296","citation_count":60,"is_preprint":false},{"pmid":"20670954","id":"PMC_20670954","title":"The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20670954","citation_count":57,"is_preprint":false},{"pmid":"32808093","id":"PMC_32808093","title":"Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.","date":"2020","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/32808093","citation_count":56,"is_preprint":false},{"pmid":"26950250","id":"PMC_26950250","title":"Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors.","date":"2016","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26950250","citation_count":56,"is_preprint":false},{"pmid":"17579028","id":"PMC_17579028","title":"A key role for Itk in both IFN gamma and IL-4 production by NKT cells.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17579028","citation_count":55,"is_preprint":false},{"pmid":"19689375","id":"PMC_19689375","title":"ITK inhibitors in inflammation and immune-mediated disorders.","date":"2009","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19689375","citation_count":53,"is_preprint":false},{"pmid":"33283362","id":"PMC_33283362","title":"Concomitant overexpression of mir-182-5p and mir-182-3p raises the possibility of IL-17-producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: A meta-analysis and experimental study.","date":"2020","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33283362","citation_count":52,"is_preprint":false},{"pmid":"9317120","id":"PMC_9317120","title":"The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9317120","citation_count":52,"is_preprint":false},{"pmid":"27780854","id":"PMC_27780854","title":"T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.","date":"2016","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/27780854","citation_count":51,"is_preprint":false},{"pmid":"16682193","id":"PMC_16682193","title":"Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors.","date":"2006","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/16682193","citation_count":50,"is_preprint":false},{"pmid":"21971040","id":"PMC_21971040","title":"Itk controls the spatiotemporal organization of T cell activation.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21971040","citation_count":45,"is_preprint":false},{"pmid":"10586033","id":"PMC_10586033","title":"Regulated association between the tyrosine kinase Emt/Itk/Tsk and phospholipase-C gamma 1 in human T lymphocytes.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10586033","citation_count":45,"is_preprint":false},{"pmid":"25593320","id":"PMC_25593320","title":"Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25593320","citation_count":43,"is_preprint":false},{"pmid":"12055226","id":"PMC_12055226","title":"The absence of Itk inhibits positive selection without changing lineage commitment.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12055226","citation_count":43,"is_preprint":false},{"pmid":"12511421","id":"PMC_12511421","title":"Rosmarinic acid inhibits Ca2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-gamma 1 and Itk activity.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12511421","citation_count":42,"is_preprint":false},{"pmid":"10570288","id":"PMC_10570288","title":"Emt/Itk associates with activated TCR complexes: role of the pleckstrin homology domain.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10570288","citation_count":41,"is_preprint":false},{"pmid":"34452995","id":"PMC_34452995","title":"Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34452995","citation_count":40,"is_preprint":false},{"pmid":"9311799","id":"PMC_9311799","title":"Antiviral immune responses in Itk-deficient mice.","date":"1997","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9311799","citation_count":40,"is_preprint":false},{"pmid":"16424186","id":"PMC_16424186","title":"Tec kinases Itk and Rlk are required for CD8+ T cell responses to virus infection independent of their role in CD4+ T cell help.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16424186","citation_count":40,"is_preprint":false},{"pmid":"31025232","id":"PMC_31025232","title":"Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.","date":"2019","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31025232","citation_count":39,"is_preprint":false},{"pmid":"9221751","id":"PMC_9221751","title":"Itk negatively regulates induction of T cell proliferation by CD28 costimulation.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9221751","citation_count":39,"is_preprint":false},{"pmid":"21212279","id":"PMC_21212279","title":"Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI-dependent mast cell responses.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21212279","citation_count":39,"is_preprint":false},{"pmid":"16436281","id":"PMC_16436281","title":"Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16436281","citation_count":38,"is_preprint":false},{"pmid":"21674762","id":"PMC_21674762","title":"Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.","date":"2011","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21674762","citation_count":38,"is_preprint":false},{"pmid":"25568116","id":"PMC_25568116","title":"Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25568116","citation_count":37,"is_preprint":false},{"pmid":"26628680","id":"PMC_26628680","title":"Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response.","date":"2015","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/26628680","citation_count":37,"is_preprint":false},{"pmid":"21391610","id":"PMC_21391610","title":"Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors.","date":"2011","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21391610","citation_count":37,"is_preprint":false},{"pmid":"38652761","id":"PMC_38652761","title":"TNF-α signals through ITK-Akt-mTOR to drive CD4+ T cell metabolic reprogramming, which is dysregulated in rheumatoid arthritis.","date":"2024","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/38652761","citation_count":36,"is_preprint":false},{"pmid":"24270545","id":"PMC_24270545","title":"CD28 and ITK signals regulate autoreactive T cell trafficking.","date":"2013","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24270545","citation_count":36,"is_preprint":false},{"pmid":"19361414","id":"PMC_19361414","title":"Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19361414","citation_count":36,"is_preprint":false},{"pmid":"21518255","id":"PMC_21518255","title":"TEC family kinases in health and disease--loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK.","date":"2011","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/21518255","citation_count":35,"is_preprint":false},{"pmid":"18941202","id":"PMC_18941202","title":"Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responses.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18941202","citation_count":35,"is_preprint":false},{"pmid":"8943565","id":"PMC_8943565","title":"CD2 signaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK.","date":"1996","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8943565","citation_count":35,"is_preprint":false},{"pmid":"9130632","id":"PMC_9130632","title":"Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9130632","citation_count":33,"is_preprint":false},{"pmid":"34368657","id":"PMC_34368657","title":"Targeting ITK signaling for T cell-mediated diseases.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/34368657","citation_count":31,"is_preprint":false},{"pmid":"25821452","id":"PMC_25821452","title":"Lipid and Protein Co-Regulation of PI3K Effectors Akt and Itk in Lymphocytes.","date":"2015","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25821452","citation_count":31,"is_preprint":false},{"pmid":"30814910","id":"PMC_30814910","title":"ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/30814910","citation_count":31,"is_preprint":false},{"pmid":"18322190","id":"PMC_18322190","title":"Differential sensitivity to Itk kinase signals for T helper 2 cytokine production and chemokine-mediated migration.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18322190","citation_count":30,"is_preprint":false},{"pmid":"26466958","id":"PMC_26466958","title":"A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease Progression.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26466958","citation_count":30,"is_preprint":false},{"pmid":"19955438","id":"PMC_19955438","title":"Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLCgamma1.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19955438","citation_count":29,"is_preprint":false},{"pmid":"11437596","id":"PMC_11437596","title":"Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.","date":"2001","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/11437596","citation_count":28,"is_preprint":false},{"pmid":"16931156","id":"PMC_16931156","title":"Itk and Th2 responses: action but no reaction.","date":"2006","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16931156","citation_count":27,"is_preprint":false},{"pmid":"34046681","id":"PMC_34046681","title":"BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34046681","citation_count":27,"is_preprint":false},{"pmid":"17060314","id":"PMC_17060314","title":"Tec kinase Itk forms membrane clusters specifically in the vicinity of recruiting receptors.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17060314","citation_count":27,"is_preprint":false},{"pmid":"19161832","id":"PMC_19161832","title":"Phylogeny of Tec family kinases identification of a premetazoan origin of Btk, Bmx, Itk, Tec, Txk, and the Btk regulator SH3BP5.","date":"2008","source":"Advances in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19161832","citation_count":27,"is_preprint":false},{"pmid":"32049330","id":"PMC_32049330","title":"Tuning T helper cell differentiation by ITK.","date":"2020","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/32049330","citation_count":26,"is_preprint":false},{"pmid":"21362141","id":"PMC_21362141","title":"Tec family kinases: Itk signaling and the development of NKT αβ and γδ T cells.","date":"2011","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/21362141","citation_count":26,"is_preprint":false},{"pmid":"30242208","id":"PMC_30242208","title":"Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30242208","citation_count":26,"is_preprint":false},{"pmid":"19111460","id":"PMC_19111460","title":"Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.","date":"2008","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/19111460","citation_count":26,"is_preprint":false},{"pmid":"17652306","id":"PMC_17652306","title":"Keeping the (kinase) party going: SLP-76 and ITK dance to the beat.","date":"2007","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/17652306","citation_count":25,"is_preprint":false},{"pmid":"11286686","id":"PMC_11286686","title":"Itk/Emt: a link between T cell antigen receptor-mediated Ca2+ events and cytoskeletal reorganization.","date":"2001","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11286686","citation_count":25,"is_preprint":false},{"pmid":"11581171","id":"PMC_11581171","title":"Nuclear localization of the tyrosine kinase Itk and interaction of its SH3 domain with karyopherin alpha (Rch1alpha).","date":"2001","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11581171","citation_count":25,"is_preprint":false},{"pmid":"36326697","id":"PMC_36326697","title":"Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36326697","citation_count":24,"is_preprint":false},{"pmid":"32640487","id":"PMC_32640487","title":"BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.","date":"2020","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/32640487","citation_count":24,"is_preprint":false},{"pmid":"20218931","id":"PMC_20218931","title":"Itk inhibitors: a patent review.","date":"2010","source":"Expert opinion on therapeutic patents","url":"https://pubmed.ncbi.nlm.nih.gov/20218931","citation_count":24,"is_preprint":false},{"pmid":"22449075","id":"PMC_22449075","title":"Regulation of T-cell responses and disease by tec kinase Itk.","date":"2012","source":"International reviews of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22449075","citation_count":24,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45237,"output_tokens":13625,"usd":0.170043,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":25765,"output_tokens":6399,"usd":0.1444,"stage2_stop_reason":"end_turn"},"total_usd":0.314443,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"ITK encodes a 72-kDa protein-tyrosine kinase specifically expressed in the T-cell lineage; its mRNA is induced by IL-2 in parallel with IL-2Rα, identifying it as an IL-2-inducible T-cell kinase.\",\n      \"method\": \"Molecular cloning, Northern blot analysis of mouse tissues and cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — original cloning and expression characterization, T-cell-specific expression replicated across many subsequent studies\",\n      \"pmids\": [\"1280821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"ITK is physically associated with CD28 in Jurkat T cells and undergoes rapid tyrosine phosphorylation and activation within 30 seconds of CD28 ligation, preceding phosphorylation of VAV, placing ITK among the earliest events in CD28 signaling.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, Western blot with phosphotyrosine antibodies\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and kinase activity assay in Jurkat cells, single lab but consistent with subsequent studies\",\n      \"pmids\": [\"7524075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Itk-deficient mice have decreased numbers of mature thymocytes and reduced T-cell proliferative responses to allogeneic MHC stimulation and anti-TCR cross-linking, but respond normally to PMA plus ionomycin or IL-2, establishing Itk as required for proximal TCR signaling events in T-cell development.\",\n      \"method\": \"Gene targeting (knockout mice), flow cytometry, proliferation assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with multiple defined phenotypic readouts, replicated across multiple subsequent studies\",\n      \"pmids\": [\"8777721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"ITK binding to CD28 is dependent on the presence of p56Lck; Lck and Fyn phosphorylate CD28 at Tyr-191 of the YMNM motif, inducing increased PI3K and GRB-2 SH2 binding to CD28, whereas ZAP-70 and ITK failed to phosphorylate CD28 at this site, placing ITK downstream of Lck in CD28 costimulatory signaling.\",\n      \"method\": \"Co-expression studies, in vitro kinase assays, SH2 domain binding assays, phosphatase digestion\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal in vitro methods, single lab, key negative result (ITK does not phosphorylate CD28 YMNM) mechanistically informative\",\n      \"pmids\": [\"7568038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Upon FcεRI cross-linking on mast cells, Itk is activated and its pleckstrin homology domain directly interacts with multiple PKC isoforms in vitro; PKC phosphorylates the PH domain of Itk and PKC isoforms co-immunoprecipitate with Itk in intact mast cells, with PKC inhibition attenuating Itk tyrosine phosphorylation and activity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, GST pulldown, PKC inhibitor treatment\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct in vitro binding and kinase assays plus cell-based co-IP, single lab\",\n      \"pmids\": [\"7561053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The Itk SH3 domain binds to proline-rich sequences in T-cell lysates; under stringent conditions it binds Sam68, Wiskott-Aldrich Syndrome protein (WASP), and hnRNP-K, overlapping but distinct from Src-family SH3 binding sites on these proteins.\",\n      \"method\": \"Phage display library screening, SH3 domain pulldown/binding assays with T-cell lysates and deletion mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vitro SH3 binding assays with multiple substrates, optimal motif defined, single lab\",\n      \"pmids\": [\"8810341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CD2 ligation induces tyrosine phosphorylation and activation of ITK in Jurkat T cells and peripheral blood T cells; this CD2-mediated activation of ITK requires LCK expression but not surface expression of the CD3 zeta chain.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, Jurkat cell mutant panel\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — kinase activity assay and co-IP with defined mutant cell lines establishing LCK requirement, single lab\",\n      \"pmids\": [\"8943565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Lck directly phosphorylates Itk at Tyr-511 in the activation loop of the kinase domain using recombinant baculovirus-expressed proteins; phosphorylation at Tyr-511 is required for Itk kinase activity, as the Y511F mutant is catalytically inactive.\",\n      \"method\": \"Baculovirus co-expression, in vitro kinase assay with recombinant proteins, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with recombinant proteins plus mutagenesis, replicated in subsequent studies\",\n      \"pmids\": [\"9312162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Src-induced activation of ITK requires PI3-kinase activity and the pleckstrin homology domain of ITK; the PH domain binds D3-phosphorylated inositol phosphates, and membrane targeting of ITK without the PH domain rescues Src-induced activation, demonstrating that PH-domain-mediated membrane recruitment is the critical step.\",\n      \"method\": \"Coexpression in COS cells, PI3K inhibitor treatment, PH domain deletion and membrane-targeting mutants, membrane fractionation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in cells with multiple domain mutants, lipid binding shown, PI3K dependence pharmacologically confirmed, single lab\",\n      \"pmids\": [\"9326591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The Itk SH3 domain forms an inducible complex with CD28 mediated by the N-terminal diproline motif of CD28; site-directed mutagenesis of the N-terminal diproline abolishes the association, and N-terminal diproline peptides activate Itk kinase activity to levels similar to CD28 cross-linking.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis of CD28 diproline motifs, peptide competition, in vitro kinase assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis defining binding site combined with co-IP and kinase activity assay, mechanistic detail confirmed\",\n      \"pmids\": [\"9317120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Itk negatively regulates CD28-mediated T-cell proliferation: Itk-deficient T cells show severely compromised CD3-mediated proliferation but significantly elevated CD28 co-stimulatory proliferative responses, indicating Itk has distinct roles in CD3 versus CD28 signaling pathways.\",\n      \"method\": \"Knockout mouse T-cell proliferation assays with anti-CD3 and anti-CD28 stimulation\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype, single lab, unexpected negative regulatory role\",\n      \"pmids\": [\"9221751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Itk is required for CD2-mediated IL-2 promoter activation and NFAT activation in Jurkat T cells; kinase-inactive Itk mutant expression reduces IL-2 promoter activity and NFAT activation downstream of CD2, TCR/CD3, and CD28 stimulation.\",\n      \"method\": \"Transient transfection of kinase-dead Itk mutant, IL-2 promoter-luciferase reporter assay, NFAT activation assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase-dead dominant-negative approach with reporter readouts, single lab\",\n      \"pmids\": [\"9130632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Itk-deficient T cells release normal calcium from intracellular stores upon TCR stimulation but fail to open plasma membrane calcium channels; TCR-induced IP3 generation and PLC-γ1 tyrosine phosphorylation are substantially reduced, while TCR-ζ and ZAP-70 are phosphorylated normally, establishing that Itk functions downstream of or in parallel to ZAP-70 to facilitate IP3 production and capacitative calcium entry.\",\n      \"method\": \"Calcium flux measurement (fura-2), thapsigargin treatment, IP3 measurement, phosphotyrosine Western blot in Itk-/- T cells\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical assays in genetic KO, replicated and extended by many subsequent studies\",\n      \"pmids\": [\"9584150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Combined deletion of Tec kinases Rlk and Itk causes marked defects in TCR-induced proliferation, cytokine production, apoptosis, and adaptive immune responses; molecular events immediately downstream of TCR are intact, but intermediate events including IP3 production, calcium mobilization, and MAP kinase activation are impaired, establishing Tec kinases as critical regulators of PLC-γ activation.\",\n      \"method\": \"Double-knockout mice, in vitro T-cell assays (proliferation, cytokine), IP3 measurement, calcium flux, ERK activation, in vivo Toxoplasma gondii infection model\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple orthogonal readouts in double-KO, in vitro and in vivo, widely replicated\",\n      \"pmids\": [\"10213685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A novel adaptor protein RIBP, identified by yeast two-hybrid screening, physically interacts with both Itk and Rlk/Txk; RIBP-knockout mice show impaired TCR-induced T-cell proliferation and defective IL-2 and IFN-γ but not IL-4 production, linking RIBP-Itk interaction to TCR signal transduction.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, knockout mouse with T-cell functional assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus genetic KO, single lab\",\n      \"pmids\": [\"10587356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ITK associates with PLC-γ1 in a TCR/CD3-regulated manner in T cells; before activation, the Itk SH3 domain mediates constitutive association with PLC-γ1, while after TCR stimulation the Itk SH2 domain dominates the enhanced interaction; the PLC-γ1 SH3 domain (but not PLC-γ1 SH2 domains) contributes to the complex.\",\n      \"method\": \"Co-immunoprecipitation with domain-specific antibodies and domain deletion mutants in Jurkat and primary T cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP with multiple domain mutants, mechanistic model for differential domain usage, single lab\",\n      \"pmids\": [\"10586033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Itk co-localizes with TCR/CD3 at the membrane upon CD3ε engagement; deletion of the Itk PH domain abolishes membrane association, activation-induced co-localization with TCR, and subsequent tyrosine phosphorylation; replacing the PH domain with an Lck membrane-targeting sequence restores membrane targeting and co-localization but not activation-induced tyrosine phosphorylation, demonstrating the PH domain has an additional function beyond membrane targeting in enabling Itk phosphorylation.\",\n      \"method\": \"Laser scanning confocal microscopy, PH domain deletion mutants, chimeric membrane-targeted Itk constructs\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging plus domain mutant analysis dissecting PH domain functions, single lab\",\n      \"pmids\": [\"10570288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Itk PH domain directs constitutive association with buoyant membrane rafts enriched in Lck and LAT; the Itk proline-rich region binds Grb2 and LAT; the Itk SH3 and SH2 domains cooperatively interact with Syk-phosphorylated SLP-76; SLP-76 contains a predicted SH2 binding motif and binds full-length Itk in vitro; kinase-inactive Itk inhibits SLP-76-dependent NFAT activation, implicating multivalent interactions recruiting Itk to LAT-nucleated signaling complexes.\",\n      \"method\": \"Membrane fractionation, co-immunoprecipitation, SH2/SH3 domain binding assays, in vitro binding, NFAT reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical and cell-based methods in one study, findings replicated by subsequent structural and signaling studies\",\n      \"pmids\": [\"10636929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Itk SH3 domain interacts with karyopherin α (Rch1α) via its proline-rich motif; TCR-CD3 stimulation increases Itk/Rch1α complex formation and recruits karyopherin β; recombinant Itk (but not Lck, ZAP-70, or Jak3) efficiently phosphorylates Rch1α in vitro; Itk shows constitutive nuclear localization that is upregulated by TCR stimulation or Rch1α overexpression; a Rch1α P242A mutant abolishes the interaction and reduces Itk nuclear localization and TCR-induced IL-2 production.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay with GST-fusion proteins, mutagenesis, immunofluorescence subcellular localization, IL-2 production assay\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay plus co-IP plus mutagenesis plus functional readout, single lab\",\n      \"pmids\": [\"11581171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Noncatalytic domains of Itk contribute to enzymatic activity: deletion of the PH/TH domain reduces catalytic activity ~10-fold; mutation of the proline-rich domain (P158A,P159A) reduces activity ~100-fold; the kinase domain alone is essentially inactive, demonstrating that N-terminal domains are required for efficient catalysis by affecting turnover rate rather than substrate binding.\",\n      \"method\": \"Recombinant protein expression and purification, steady-state kinetic analysis (kcat, Km), in vitro kinase assay with SAM68 substrate\",\n      \"journal\": \"Protein expression and purification\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase reconstitution with purified recombinant proteins and quantitative kinetic analysis of multiple domain mutants, single lab\",\n      \"pmids\": [\"11437596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Cyclophilin A (CypA) inhibits Itk catalytic activity through its peptidyl-prolyl isomerase activity; NMR structural studies show a proline-dependent conformational switch in the Itk SH2 domain regulates substrate recognition and mediates interaction with CypA; CypA and Itk form a stable complex in Jurkat T cells that is disrupted by cyclosporin A; cyclosporin A treatment increases phosphorylation of Itk and its substrate PLC-γ1.\",\n      \"method\": \"NMR spectroscopy, mutagenesis, co-immunoprecipitation from Jurkat cells, cyclosporin A treatment, phosphorylation Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure with mutagenesis plus cell-based co-IP and pharmacological validation in one study\",\n      \"pmids\": [\"11830645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Itk is required for efficient NKT cell maturation; Itk-deficient mice have reduced NKT cell numbers with a predominantly immature phenotype, and progressive decrease of NKT cells in older mice, establishing a role for Itk in NKT cell development and peripheral maintenance.\",\n      \"method\": \"CD1d tetramer staining, flow cytometry, Itk-/- mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined phenotypic readout using CD1d tetramers, single lab\",\n      \"pmids\": [\"12193707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Absence of Itk impairs positive thymic selection at multiple stages but does not affect CD4/CD8 lineage commitment; fewer TCR transgenic T cells develop without Itk, but those that do appear normal in lineage markers.\",\n      \"method\": \"Itk-/- mice crossed to TCR transgenic lines on multiple MHC backgrounds, flow cytometry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in multiple TCR transgenic backgrounds, clear phenotypic readout, single lab\",\n      \"pmids\": [\"12055226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Itk autophosphorylates at Tyr-180 in the SH3 domain; mutation of either the trans-phosphorylation site (Y511F) or the autophosphorylation site (Y180F) impairs full restoration of cytokine production and ERK activation in Itk-deficient primary T cells; an SH3 point mutant unable to bind ligand also fails to restore function, demonstrating both phosphorylation events and SH3 ligand binding are required for Itk function.\",\n      \"method\": \"Retroviral transduction of Itk point mutants into Itk-/- primary T cells, cytokine production assay, ERK activation Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple site-specific mutants in primary T cells with functional readouts, mechanistic dissection replicated findings from earlier in vitro work\",\n      \"pmids\": [\"12842872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Selective small-molecule ITK inhibitors (BMS-488516 and BMS-509744) potently inhibit Itk kinase activity and reduce TCR-induced PLC-γ1 tyrosine phosphorylation, calcium mobilization, IL-2 secretion, and T-cell proliferation in human and mouse cells; BMS-509744 reduces lung inflammation in an ovalbumin mouse asthma model, validating ITK as a target downstream of PLCγ in TCR signaling.\",\n      \"method\": \"In vitro kinase assay, biochemical T-cell signaling assays (PLCγ1 phosphorylation, calcium flux), IL-2 ELISA, proliferation assay, in vivo mouse asthma model\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with biochemical pathway validation and in vivo model, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"15323564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Itk signaling promotes Th2 differentiation by negatively regulating T-bet expression; in the absence of skewing cytokines with low-avidity ligands, wild-type T cells preferentially express GATA-3 and become Th2, while Itk-/- T cells produce T-bet and become IFN-γ-producing cells; Itk expression is upregulated during Th2 differentiation while Rlk disappears from Th2 cells.\",\n      \"method\": \"Itk-/- mice, in vitro T-cell differentiation assays, cytokine measurement, RT-PCR for T-bet and GATA-3\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with mechanistic transcription factor readout, single lab\",\n      \"pmids\": [\"15345221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ITK is activated by CXCL12/SDF-1α stimulation through CXCR4 via Src and PI3K activities; ITK regulates CXCR4-mediated T-cell migration and adhesion by altering actin polymerization, as ITK-null T cells show defective CXCL12-induced actin polymerization, migration, and adhesion.\",\n      \"method\": \"Kinase activation assay, Src and PI3K inhibitors, migration assay, adhesion assay, actin polymerization assay in Itk-/- T cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus pharmacological inhibition with multiple functional readouts, single lab\",\n      \"pmids\": [\"15123627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Itk has a kinase-independent scaffolding function in TCR-induced actin polarization; siRNA-mediated knockdown of Itk or expression of kinase-inactive Itk rescues actin polarization defect; PH domain and SH2 domain mutations abolish this activity; Itk is constitutively associated with Vav and loss of Itk disrupts Vav localization to the immune synapse and Vav-SLP-76 interactions without altering bulk Vav tyrosine phosphorylation; membrane-targeted Vav-CAAX rescues the actin polarization defect.\",\n      \"method\": \"siRNA knockdown, kinase-dead mutant rescue, confocal microscopy for actin polarization, co-immunoprecipitation, membrane-targeted Vav-CAAX rescue experiment\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (RNAi, kinase-dead mutant, domain mutants, co-IP, rescue with membrane-targeted Vav) in one study, mechanistic dissection of scaffolding vs. catalytic function\",\n      \"pmids\": [\"15661896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Itk and Rlk deficiency causes CD8+ single-positive thymocytes and peripheral CD8+ T cells to acquire an innate-like phenotype (CD44hi, CD122+, NK1.1+, rapid IFN-γ production, IL-15-dependent, eomesodermin-expressing); expression of a hypersensitive ERK2 mutant partially corrects CD8+ T cell phenotypes in Itk-/- mice, establishing that altered Tec kinase signaling allows development of innate-type CD8+ cells.\",\n      \"method\": \"Itk-/- and Rlk-/-Itk-/- mice, flow cytometry, cytokine production, hematopoietic chimeras, hypersensitive ERK2 transgene rescue\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with transgenic rescue, multiple phenotypic readouts, replicated simultaneously by another lab (PMID:16860759)\",\n      \"pmids\": [\"16860760\", \"16860759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The t(5;9)(q33;q22) translocation found in 17% of unspecified PTCL fuses the N-terminal PH domain and proline-rich region of ITK to the tyrosine kinase domain of SYK, creating an ITK-SYK fusion kinase that drives oncogenesis.\",\n      \"method\": \"Molecular cytogenetics (FISH), RT-PCR, sequencing of breakpoints in patient samples\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — identification of recurrent fusion in 5/30 patient samples with identical breakpoints, molecular characterization of fusion transcript\",\n      \"pmids\": [\"16341044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Itk forms membrane clusters of at least two molecules within 80 Å upon membrane recruitment via its PH domain; clustering requires PH domain integrity but not the proline-rich region, SH3, SH2 domains, or kinase activity; these clusters form specifically in membrane regions co-occupied by receptors that recruit PI3K.\",\n      \"method\": \"FRET microscopy, domain deletion mutants, membrane fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET-based localization with domain mutant analysis, single lab\",\n      \"pmids\": [\"17060314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NMR structure of the Itk SH2 domain bound to a phosphotyrosine peptide reveals that prolyl cis/trans isomerization controls two distinct SH2 conformers; the trans conformer preferentially binds the phosphopeptide; the BG loop in the free trans conformer is pre-arranged for pY+3 contacts; pY binding propagates structural changes to the CD loop and αB helix, providing the structural basis for CypA-regulated conformational switching.\",\n      \"method\": \"NMR spectroscopy, trans-hydrogen bond scalar coupling analysis, structure determination\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with mechanistic hydrogen-bond coupling analysis, builds on CypA functional study\",\n      \"pmids\": [\"16436281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SLP-76 is required for TCR-induced tyrosine phosphorylation and activation of ITK (but not ZAP-70); ITK specifically and efficiently phosphorylates PLC-γ1 at Y783 and Y775 in vitro whereas ZAP-70 does not; a fraction of active ITK binds SLP-76 in stimulated cells, and catalytic activity is lost upon mild elution from the SLP-76 complex but restored upon reconstitution, establishing that ongoing SLP-76 association is required to maintain ITK in an active conformation.\",\n      \"method\": \"In vitro kinase assay with recombinant proteins (ITK vs ZAP-70 side-by-side), co-immunoprecipitation from TCR-stimulated cells, complex elution and reconstitution, SLP-76 mutant analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase reconstitution identifying direct substrates plus mechanistic complex reconstitution/dissociation experiments, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"17420479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Itk differentially regulates distinct NK cell-activating pathways in a catalytic-activity-dependent manner: enhanced Itk expression increases calcium mobilization, granule release, and cytotoxicity via the ITAM-containing FcR, but decreases cytotoxicity and granule release downstream of the NKG2D receptor; a kinase-dead Itk mutant abolishes both effects.\",\n      \"method\": \"Itk overexpression and knockdown in human NK cells, cytotoxicity assays, calcium flux, granule release assay, kinase-dead mutant\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with kinase-dead mutant, multiple functional readouts, single lab\",\n      \"pmids\": [\"17339454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Loss of ITK function (via ITK-specific siRNA, kinase-inactive mutant, or ITK inhibitor) markedly reduces intracellular HIV p24 levels; ITK inhibition partially blocks HIV viral entry (correlating with decreased actin polarization to gp120) and reduces HIV transcription; overexpression of ITK increases viral transcription and virus-like particle formation; ITK does not affect CD4 or CXCR4 expression.\",\n      \"method\": \"siRNA knockdown, kinase-inactive ITK mutant, ITK inhibitor, HIV infection assay, p24 ELISA, actin polarization imaging, viral transcription assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — three complementary loss-of-function approaches with multiple mechanistic readouts, single lab\",\n      \"pmids\": [\"18443296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NMR structure of the binary Itk SH3/SH2 complex reveals a nonclassical interaction independent of phosphotyrosine motifs and proline-rich sequences; the higher-affinity cis SH2 conformer (controlled by prolyl isomerization) is preorganized to form a hydrophobic interface with the SH3 domain; autophosphorylation in the Itk SH3 domain is predicted to increase intermolecular SH3/SH2 affinity.\",\n      \"method\": \"NMR spectroscopy, structure determination of SH3/SH2 binary complex\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure determination revealing nonclassical domain-domain interaction mechanism, mechanistic insight built on prior structural and biochemical studies\",\n      \"pmids\": [\"19361414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Itk phosphorylation and activation of PLC-γ1 requires a direct phosphotyrosine-independent docking interaction between the Itk kinase domain and the nSH2 domain of PLC-γ1; disruption of this docking interface by mutagenesis attenuates T-cell signaling.\",\n      \"method\": \"NMR spectroscopy, mutagenesis of docking interface, T-cell signaling assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR-defined docking interface with mutagenesis validated by T-cell functional assay, single lab\",\n      \"pmids\": [\"19955438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Itk signaling in γδ T cells controls IgE production in vivo; Itk-/- γδ T cells produce high levels of Th2 cytokines when stimulated through the γδ TCR; Itk-/-Tcrd-/- mice have normal IgE levels; activated Itk-/- γδ T cells upregulate costimulatory molecules for B cell help; increased Vγ1.1+Vδ6.3+ γδ NKT cells with increased PLZF expression are found in Itk-/- mice.\",\n      \"method\": \"Itk-/- and Itk-/-Tcrd-/- mice, serum IgE measurement, γδ T cell isolation and stimulation, cytokine assay, flow cytometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double-KO genetic epistasis establishing γδ T cell-specific mechanism for IgE dysregulation, multiple readouts, single lab\",\n      \"pmids\": [\"19416854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ITK-SYK fusion kinase constitutively associates with lipid rafts in T cells and triggers antigen-independent phosphorylation of TCR-proximal signaling proteins, leading to activation of downstream pathways that mimic regular TCR ligation (CD69 upregulation, IL-2 production in vitro, thymocyte deletion and T-cell activation in vivo); conditional expression in mice induces highly malignant PTCL with 100% penetrance.\",\n      \"method\": \"Lipid raft fractionation, phosphorylation assays, in vitro T-cell activation assays, conditional transgenic mouse model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic dissection of fusion kinase signaling with both in vitro and in vivo confirmation, 100% penetrant disease model, replicated by second group (PMID:20670954)\",\n      \"pmids\": [\"20439541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ITK-SYK-induced T-cell lymphoproliferative disease in mice requires SYK kinase activity; membrane localization of ITK-SYK via its PH domain is not required for disease development (PH domain R29C mutant enhances rather than abolishes disease); CBL binding to membrane-associated ITK-SYK (E42K mutant) delays disease development.\",\n      \"method\": \"Bone marrow transplantation model, SYK kinase inhibitor treatment, point mutants (R29C, E42K) in mouse disease model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mouse model with pharmacological inhibition and defined point mutants, single lab\",\n      \"pmids\": [\"20670954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss of Itk alters the spatiotemporal distribution of 14 of 16 signaling sensors at the T cell–APC interface; Cdc42 activation at the center of the interface is impaired (total active Cdc42 unchanged); reconstitution with interface-targeted active Cdc42 restores actin accumulation in Itk-/- T cells; Itk controls central localization of SLAT, which contributes to Cdc42 activation at the interface.\",\n      \"method\": \"Live-cell imaging with signaling biosensors/sensors, Itk-/- mice, targeted active Cdc42 rescue construct, confocal microscopy\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic spatiotemporal imaging of 16 sensors plus mechanistic rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"21971040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Itk and Btk double-knockout mast cells show severely impaired FcεRI-induced degranulation and cytokine secretion, with significant reduction in PLC-γ2 phosphorylation, impaired calcium responses, and altered NFAT1 nuclear localization; network analysis suggests Itk plays both positive and negative roles while Btk primarily plays a positive role in mast cell FcεRI cytokine secretion.\",\n      \"method\": \"Itk/Btk double-KO mice, BMMC generation, degranulation assay, cytokine ELISA, calcium flux, PLC-γ2 phosphorylation Western blot, NFAT1 nuclear localization imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-KO with multiple orthogonal biochemical readouts, mechanistic dissection of Itk vs Btk contributions\",\n      \"pmids\": [\"21212279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The Itk PH domain binds most prominently to phosphatidylinositol monophosphates (PI(3)P, PI(4)P, PI(5)P) and to a lesser extent to PIP2 and PIP3; an ITK R29H patient mutation (in the PH domain) dramatically reduces these phosphoinositide interactions, abolishes rescue of calcium flux in Itk-/- T cells, and reduces protein half-life.\",\n      \"method\": \"Lipid binding assay (phosphoinositide strips/liposome binding), calcium flux rescue assay in Itk-/- T cells, pulse-chase protein stability assay\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct lipid binding assay plus functional rescue plus protein stability measurement in one study, single lab\",\n      \"pmids\": [\"22289921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ITK signaling promotes IRF4 upregulation in CD8+ T cells following TCR stimulation; ITK inhibitor treatment impairs IRF4 induction; in IRF4-deficient CD8+ T cells, TCR activation leads to rapid Eomesodermin upregulation (further enhanced by IL-4), establishing that ITK-IRF4 signaling normally suppresses Eomes and regulates conventional vs innate CD8+ T-cell fate.\",\n      \"method\": \"Small-molecule ITK inhibitor, IRF4-knockout mice, ITK inhibitor treatment, flow cytometry and RT-PCR for IRF4 and Eomes expression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological ITK inhibition and genetic IRF4 KO with mechanistic transcription factor readouts, single lab\",\n      \"pmids\": [\"23011795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ibrutinib irreversibly inhibits ITK in T cells (in addition to BTK in B cells); ibrutinib treatment drives a Th1-selective pressure by ablating Th2 immunity; ITK is confirmed as a covalent irreversible target of ibrutinib in T cells using clinical trial samples and disease models.\",\n      \"method\": \"In silico docking, biochemical kinase assays, molecular analysis of T cells from ibrutinib clinical trial patients, Leishmania and Listeria infection models\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical confirmation of irreversible ITK inhibition combined with clinical patient samples and multiple in vivo disease models\",\n      \"pmids\": [\"23886836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD28 and ITK signals regulate autoreactive T-cell trafficking to tissues; loss of ITK in Ctla4-/- mice does not block T-cell activation but causes self-reactive T cells to accumulate in secondary lymphoid organs instead of entering tissues; ITK inhibitors phenocopy the null mutant and prevent pancreatic islet infiltration by diabetogenic T cells.\",\n      \"method\": \"Itk-/-;Ctla4-/- double-knockout mice, adoptive transfer, ITK inhibitor treatment in type 1 diabetes mouse model, tissue histology\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-KO genetic epistasis plus pharmacological inhibition with in vivo tissue trafficking readout, two complementary approaches\",\n      \"pmids\": [\"24270545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Itk deficiency increases sensitivity to IL-2 signaling and skews CD4+ T-cell differentiation toward Foxp3+ Treg cells; Itk-/- T cells show reduced TCR-induced mTOR target phosphorylation and impaired mTOR activation by IL-2; TCR stimulation normally represses Pten in a dose-dependent manner, but in the absence of Itk, Pten is not repressed, uncoupling STAT5 and PI3K signaling; Itk-deficient cells show impaired TCR-mediated induction of Myc and miR-19b (known Pten repressors).\",\n      \"method\": \"Itk-/- mice, in vitro Th17/Treg differentiation, mTOR target phosphorylation (S6K, 4EBP1), STAT5 phosphorylation, Pten expression, Myc/miR-19b expression, in vivo Treg development\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical measurements with genetic KO establishing mechanistic pathway (ITK→mTOR/PI3K→Pten→Treg/Th17 balance), single lab with extensive controls\",\n      \"pmids\": [\"24534190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PRN694 covalently binds to Cys442 of ITK (and Cys350 of RLK) in the kinase domain, blocking kinase activity with extended target residence time; it prevents TCR- and Fc receptor-induced cellular activation, inhibits T-cell proliferation, blocks proinflammatory cytokine release, inhibits Th17 cell activation, and shows in vivo pharmacodynamic effects reducing delayed-type hypersensitivity.\",\n      \"method\": \"Molecular modeling, biochemical kinase assay, cysteine-targeting covalent binding characterization, in vitro T-cell functional assays, ex vivo T-PLL cell assays, in vivo DTH model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — molecular modeling plus biochemical covalent binding characterization plus multiple functional assays in vitro and in vivo, single lab\",\n      \"pmids\": [\"25593320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4; Itk-/- CD4+ T cells under Th9 conditions fail to produce IL-9 and have reduced IRF4 levels; IL-9 and IRF4 expression are rescued by exogenous IL-2 or constitutively active STAT5 but not NFATc1; STAT5 binds the Irf4 promoter; Itk inhibition also reduces IL-9 expression in human T cells.\",\n      \"method\": \"Itk-/- mice, Th9 in vitro differentiation, cytokine measurement, STAT5 ChIP at Irf4 promoter, constitutively active STAT5 rescue, ITK inhibitor in human T cells, mouse asthma model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus ChIP plus rescue experiments plus pharmacological inhibition in human cells, multiple orthogonal methods, replicated in vivo\",\n      \"pmids\": [\"26936133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TCR signaling activates an ITK-NF-κB-GATA-3 axis that promotes chemotherapy resistance in T-cell lymphomas; pharmacological inhibition of ITK prevents activation of this signaling axis and overcomes chemotherapy resistance.\",\n      \"method\": \"Genetic and pharmacological inhibition of ITK in primary T-cell lymphoma cells and patient-derived cell lines, NF-κB and GATA-3 activation assays, chemotherapy resistance assays\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological approaches in patient-derived cells with defined pathway readout, single lab\",\n      \"pmids\": [\"27780854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ITK signaling through the Ras/IRF4 pathway is required for functional Tr1 cell development; ITK kinase activity is required for mouse and human Tr1 differentiation; expression of constitutively active HRas rescues IRF4 expression and Tr1 differentiation in Itk-/- cells; IRF4 expression also rescues Tr1 suppressive function in Itk-/- cells.\",\n      \"method\": \"Itk-/- mice, in vitro and in vivo Tr1 differentiation, constitutively active HRas rescue, IRF4 rescue, ITK kinase inhibitor in human T cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus constitutively active Ras rescue plus IRF4 rescue plus human cell pharmacological validation, multiple orthogonal approaches\",\n      \"pmids\": [\"28635957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ITK preferentially aids NF-κB activation downstream of the TCR; NF-κB shows dynamic graded activation in response to TCR signal strength that is dampened by ITK inhibitor; ITK inhibitor-treated cells show reduced AP-1 factors (Fos, Fosb), NF-κB response gene transcripts, and IL-2 transcripts; ATAC-seq shows ITK-sensitive genomic regions are enriched for NF-κB and AP-1 motifs; NFAT1 and Erk1/2 activation is digital and less sensitive to ITK inhibition.\",\n      \"method\": \"ITK inhibitor treatment, single-cell nuclear NFAT1/NF-κB/Erk1/2 imaging, ATAC-seq, gene expression analysis in naïve CD8+ OT-I cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pharmacological ITK inhibition with single-cell imaging of transcription factor activation plus genome-wide chromatin accessibility and transcriptomics, multiple orthogonal methods\",\n      \"pmids\": [\"34452995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TNF-α released by activated human naïve CD4+ T cells stimulates metabolic reprogramming (increased glycolysis, amino acid uptake, glutamine oxidation, mitochondrial biogenesis) through ITK-mediated activation of Akt-mTOR signaling, independently of NF-κB; TNF-α also drives Th1 and Th17 but not Treg differentiation via this ITK-Akt-mTOR axis.\",\n      \"method\": \"Human naïve CD4+ T-cell activation assays, ITK inhibitor, Akt phosphorylation measurement, metabolic flux analysis, T-cell differentiation assays, RA patient samples\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological ITK inhibition with metabolic and signaling readouts in primary human cells, NF-κB pathway ruled out, single lab\",\n      \"pmids\": [\"38652761\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ITK is a Tec-family non-receptor tyrosine kinase expressed predominantly in T cells that is activated downstream of the TCR (and CD28/CD2/CXCR4/FcεRI) via a sequential mechanism: PI3K generates PIP3 that recruits ITK to the plasma membrane via its PH domain; Lck then trans-phosphorylates the activation loop at Tyr-511 to activate ITK; SLP-76 association (via ITK SH3/SH2 domains) is required to maintain ITK in an active conformation; active ITK directly phosphorylates PLC-γ1 at Y783/Y775 through a docking interaction between the ITK kinase domain and the PLC-γ1 nSH2 domain, driving IP3 production, calcium influx, and downstream NFAT/NF-κB/AP-1 activation; ITK also performs kinase-independent scaffolding functions (through its PH, SH2 domains) to localize Vav to the immune synapse for actin polarization; ITK activity is negatively regulated by cyclophilin A-mediated prolyl isomerization of its SH2 domain, while autophosphorylation at Tyr-180 in the SH3 domain provides an additional regulatory layer; in vivo, ITK is required for positive thymic selection, Th2/Th9/Tr1 differentiation, NKT cell maturation, and conventional CD8+ T-cell development, while its absence promotes innate-like T-cell phenotypes and Treg/Th1 skewing via altered mTOR-Pten-IRF4 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ITK is a T-cell-lineage-restricted, IL-2-inducible Tec-family non-receptor tyrosine kinase that couples antigen-receptor engagement to phospholipase C-γ1 activation, calcium flux, and downstream transcriptional programs governing T-cell development and effector differentiation [#0, #12]. Activation proceeds by sequential, domain-coordinated steps: PI3-kinase-dependent membrane recruitment through the ITK pleckstrin-homology domain — which binds D3-phosphorylated phosphoinositides and drives membrane clustering — positions ITK at receptor-proximal sites, and this PH-domain function is the critical step in Src/Lck-induced activation [#8, #30, #42]. Lck then directly trans-phosphorylates the activation-loop residue Tyr-511, an event required for catalytic activity, while autophosphorylation at Tyr-180 in the SH3 domain and ligand binding by the SH3 domain provide additional layers of regulation [#7, #23]. ITK is recruited into LAT/SLP-76-nucleated signaling complexes through cooperative SH3/SH2 and proline-rich interactions, and ongoing SLP-76 association is required to maintain ITK in an active conformation [#17, #32]. Active ITK selectively phosphorylates PLC-γ1 at Y775/Y783 via a direct, phosphotyrosine-independent docking interaction between the ITK kinase domain and the PLC-γ1 nSH2 domain, driving IP3 production and capacitative calcium entry that ZAP-70 cannot supply [#32, #36, #12]. Catalytic output is restrained by cyclophilin A, whose prolyl-isomerase activity exploits a cis/trans conformational switch in the ITK SH2 domain to inhibit kinase activity and modulate substrate recognition [#20, #31]. Beyond its catalytic role, ITK performs a kinase-independent scaffolding function via its PH and SH2 domains to localize Vav to the immune synapse and organize Cdc42-dependent actin polarization at the T-cell–APC interface [#27, #40]. Genetically, ITK is required for proximal TCR signaling, positive thymic selection, NKT cell maturation, and Th2/Th9/Tr1 differentiation, and shapes the conventional-versus-innate CD8+ T-cell fate decision through an mTOR/Pten and IRF4/Eomes axis; its loss promotes innate-like T cells and Treg/Th1 skewing [#2, #22, #21, #25, #46, #43, #50]. A recurrent t(5;9) translocation fuses the ITK PH and proline-rich region to the SYK kinase domain, generating a constitutively active fusion kinase that drives peripheral T-cell lymphoma [#29, #38], and ITK is a covalent off-target of the BTK inhibitor ibrutinib [#44].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing ITK's identity answered whether a dedicated, lineage-restricted tyrosine kinase exists in T cells, defining it as an IL-2-inducible enzyme of the T-cell compartment.\",\n      \"evidence\": \"Molecular cloning and Northern blot of mouse tissues and cell lines\",\n      \"pmids\": [\"1280821\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional or signaling role defined\", \"No domain mechanism established\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Knockout mice answered whether ITK is functionally required, placing it in proximal TCR signaling rather than the distal PMA/ionomycin or IL-2 pathways.\",\n      \"evidence\": \"Gene targeting, flow cytometry, proliferation assays with TCR/MHC versus PMA+ionomycin/IL-2 stimulation\",\n      \"pmids\": [\"8777721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular substrate not identified\", \"Step in the TCR cascade not pinpointed\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"In vitro reconstitution answered how ITK is switched on, showing Lck directly phosphorylates the activation-loop Tyr-511, and that PI3K-dependent PH-domain membrane recruitment is the critical upstream step.\",\n      \"evidence\": \"Baculovirus recombinant kinase assays with Y511F mutagenesis; PH-domain deletion and membrane-targeting rescue with PI3K inhibitors\",\n      \"pmids\": [\"9312162\", \"9326591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PH domain has a function beyond membrane targeting that was undefined at the time\", \"Direct physiological substrate not yet established\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Biochemical dissection in knockout T cells answered where ITK acts in the cascade, showing it lies downstream of/parallel to ZAP-70 and is required for IP3 generation, PLC-γ1 phosphorylation, and capacitative calcium entry.\",\n      \"evidence\": \"Calcium flux (fura-2), IP3 measurement, phosphotyrosine blots, thapsigargin in Itk-/- T cells\",\n      \"pmids\": [\"9584150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect PLC-γ1 phosphorylation not resolved\", \"Recruitment mechanism into the signaling complex unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Genetic epistasis with Rlk and adaptor/PLC-γ1 association studies answered how ITK is wired into the TCR complex, establishing Tec kinases as critical PLC-γ regulators recruited via SH3/SH2 domains.\",\n      \"evidence\": \"Rlk/Itk double-knockout mice with IP3/calcium/ERK readouts and in vivo infection; co-IP with PLC-γ1 domain mutants; RIBP yeast two-hybrid and knockout\",\n      \"pmids\": [\"10213685\", \"10586033\", \"10587356\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct kinase-substrate relationship with PLC-γ1 not yet proven in vitro\", \"Docking interface unmapped\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapping ITK's multivalent interactions answered how it is concentrated at the membrane, showing PH-domain raft targeting plus cooperative SH3/SH2 engagement of Syk-phosphorylated SLP-76 and proline-rich binding to Grb2/LAT.\",\n      \"evidence\": \"Membrane fractionation, co-IP, SH2/SH3 binding assays, NFAT reporter with kinase-dead ITK\",\n      \"pmids\": [\"10636929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SLP-76 binding regulates catalytic state not yet shown\", \"Stoichiometry of the complex undefined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Structural and biochemical work answered how ITK catalytic activity is restrained, identifying cyclophilin A prolyl-isomerase-driven cis/trans switching of the SH2 domain as a negative regulator.\",\n      \"evidence\": \"NMR of the SH2 domain, mutagenesis, co-IP from Jurkat cells, cyclosporin A treatment with phospho-PLC-γ1 readout\",\n      \"pmids\": [\"11830645\", \"16436281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger for CypA engagement in vivo not defined\", \"Quantitative contribution to overall ITK output unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mutational reconstitution in primary T cells answered which regulatory events are functionally required, showing both Tyr-511 trans-phosphorylation, Tyr-180 SH3 autophosphorylation, and SH3 ligand binding are each needed for full function.\",\n      \"evidence\": \"Retroviral transduction of Itk point mutants into Itk-/- T cells with cytokine and ERK readouts\",\n      \"pmids\": [\"12842872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SH3 ligand identity in vivo not pinned down\", \"Order of phosphorylation events not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Separation-of-function experiments answered whether ITK has roles beyond catalysis, defining a kinase-independent scaffolding function that localizes Vav to drive actin polarization.\",\n      \"evidence\": \"siRNA, kinase-dead and PH/SH2 domain mutants, co-IP, confocal actin imaging, membrane-targeted Vav-CAAX rescue\",\n      \"pmids\": [\"15661896\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Vav is held by ITK structurally undefined\", \"Relationship to catalytic signaling at the synapse unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Side-by-side in vitro kinase reconstitution answered whether ITK directly phosphorylates PLC-γ1, identifying Y775/Y783 as specific ITK (not ZAP-70) sites and showing SLP-76 association maintains the active conformation.\",\n      \"evidence\": \"Recombinant ITK vs ZAP-70 kinase assays, co-IP, complex elution/reconstitution, SLP-76 mutants\",\n      \"pmids\": [\"17420479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of substrate selectivity not yet defined\", \"Mechanism of conformational maintenance by SLP-76 unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"NMR structures answered how ITK domains coordinate substrate engagement, revealing a nonclassical SH3/SH2 interface tuned by prolyl isomerization and a phosphotyrosine-independent kinase-domain docking onto the PLC-γ1 nSH2 domain.\",\n      \"evidence\": \"NMR structure determination of the SH3/SH2 binary complex and of the ITK-PLC-γ1 docking interface with mutagenesis and T-cell signaling assays\",\n      \"pmids\": [\"19361414\", \"19955438\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length autoinhibited architecture not solved\", \"Allosteric coupling between domains in vivo not quantified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Phenotypic and genetic-rescue studies answered how ITK governs CD8 T-cell identity, showing Tec kinase loss yields innate-like CD8+ cells correctable by enhanced ERK signaling.\",\n      \"evidence\": \"Itk-/- and Rlk-/-Itk-/- mice, chimeras, hypersensitive ERK2 transgene rescue; NKT and thymic selection phenotyping\",\n      \"pmids\": [\"16860760\", \"12193707\", \"12055226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional effectors not yet identified at this stage\", \"Cell-intrinsic versus -extrinsic contributions partly unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Transcription-factor and pathway analyses answered how ITK signal strength is decoded into fate, linking ITK to IRF4 induction and Eomes suppression and to PH-domain phosphoinositide binding affected by a patient mutation.\",\n      \"evidence\": \"ITK inhibitor and IRF4-knockout mice for Eomes readout; lipid binding assays, calcium-rescue, and protein stability for the R29H PH-domain mutation\",\n      \"pmids\": [\"23011795\", \"22289921\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ITK targets upstream of IRF4 not mapped\", \"Clinical genotype-phenotype correlation limited\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mechanistic pathway dissection answered how ITK biases CD4 differentiation, showing ITK loss derepresses Pten and dampens mTOR, skewing toward Foxp3+ Treg, and that ITK promotes Th9/Tr1 via IL-2/STAT5/IRF4 and Ras/IRF4 axes.\",\n      \"evidence\": \"Itk-/- mice with mTOR/STAT5/Pten/Myc readouts; STAT5 ChIP at Irf4, constitutively active STAT5 and HRas rescue, ITK inhibitor in human cells\",\n      \"pmids\": [\"24534190\", \"26936133\", \"28635957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ITK substrates linking to Pten/Myc not identified\", \"Hierarchy among parallel differentiation axes unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Single-cell and genome-wide analyses answered which transcriptional outputs ITK preferentially tunes, showing ITK shapes graded NF-κB and AP-1 activation while NFAT1/ERK responses are more digital and ITK-insensitive.\",\n      \"evidence\": \"ITK inhibitor with single-cell NFAT1/NF-κB/ERK imaging, ATAC-seq, transcriptomics in naïve CD8+ OT-I cells; earlier CD2/IL-2 promoter and NFAT reporter work\",\n      \"pmids\": [\"34452995\", \"9130632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link from ITK to NF-κB/AP-1 not fully mapped\", \"Generalizability across T-cell subsets untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Characterization of the ITK-SYK fusion answered how ITK contributes to lymphomagenesis, showing the fusion constitutively activates TCR-proximal signaling and drives fully penetrant peripheral T-cell lymphoma requiring SYK activity.\",\n      \"evidence\": \"Cytogenetics/RT-PCR in patient samples; lipid raft fractionation, in vitro activation assays, conditional transgenic and bone-marrow transplant mouse models with R29C/E42K mutants and SYK inhibition\",\n      \"pmids\": [\"16341044\", \"20439541\", \"20670954\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of native ITK (versus fusion) to lymphoma unclear\", \"Membrane-localization requirement context-dependent\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Inhibitor and pharmacology studies answered whether ITK is a tractable drug target, defining covalent active-site cysteines, ibrutinib off-target inhibition, and in vivo immunomodulatory and trafficking effects.\",\n      \"evidence\": \"Selective and covalent inhibitors (BMS-509744, PRN694 targeting Cys442), ibrutinib clinical samples and infection models; Itk-/-;Ctla4-/- trafficking studies\",\n      \"pmids\": [\"25593320\", \"23886836\", \"15323564\", \"24270545\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term immune consequences of chronic ITK inhibition undefined\", \"Selectivity over other Tec kinases incomplete\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Metabolic profiling answered how ITK couples cytokine cues to T-cell metabolism, showing TNF-α drives glycolytic/mitochondrial reprogramming and Th1/Th17 bias through ITK-Akt-mTOR independently of NF-κB.\",\n      \"evidence\": \"ITK inhibitor in human naïve CD4+ T cells, Akt phosphorylation, metabolic flux analysis, differentiation assays, RA patient samples\",\n      \"pmids\": [\"38652761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ITK substrate in the Akt-mTOR arm not identified\", \"In vivo relevance of the TNF-ITK-mTOR axis untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ITK's catalytic and kinase-independent scaffolding functions are integrated within a single full-length autoregulated molecule at the immune synapse, and which direct substrates link ITK to the NF-κB/AP-1 and Pten/mTOR programs, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length autoinhibited structure\", \"Direct substrates beyond PLC-γ1 largely uncatalogued\", \"Mechanism linking ITK activity to NF-κB and Pten regulation unmapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [7, 32, 36]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [7, 32, 18, 19]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [8, 42, 30]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [27, 17]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [27, 40]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 16, 17, 30]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 12, 13, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 32, 36, 51]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 22, 25, 28, 46]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [29, 38, 49]}\n    ],\n    \"complexes\": [\n      \"LAT/SLP-76 signalosome\"\n    ],\n    \"partners\": [\n      \"LCK\",\n      \"SLP-76\",\n      \"PLCG1\",\n      \"VAV1\",\n      \"CD28\",\n      \"GRB2\",\n      \"LAT\",\n      \"PPIA\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}